<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS202049</article-id><article-id pub-id-type="doi">10.1101/2024.12.14.628483</article-id><article-id pub-id-type="archive">PPR954710</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title><italic>Salmonella</italic> multimutants enable efficient identification of SPI-2 effector protein function in gut inflammation and systemic colonization</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Newson</surname><given-names>Joshua P. M.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gürtler</surname><given-names>Flavia</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">2</xref></contrib><contrib contrib-type="author"><name><surname>Piffaretti</surname><given-names>Pietro</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Meyer</surname><given-names>Annina</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN2">3</xref></contrib><contrib contrib-type="author"><name><surname>Sintsova</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Barthel</surname><given-names>Manja</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Steiger</surname><given-names>Yves</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>McHugh</surname><given-names>Sarah C.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN3">4</xref></contrib><contrib contrib-type="author"><name><surname>Enz</surname><given-names>Ursina</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Alto</surname><given-names>Neal M.</given-names></name><xref ref-type="aff" rid="A2">5</xref></contrib><contrib contrib-type="author"><name><surname>Sunagawa</surname><given-names>Shinichi</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hardt</surname><given-names>Wolf-Dietrich</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Institute of Microbiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05a28rw58</institution-id><institution>ETH Zurich</institution></institution-wrap>, <city>Zurich</city>, <country country="CH">Switzerland</country></aff><aff id="A2"><label>5</label>Department of Microbiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05byvp690</institution-id><institution>University of Texas (UT) Southwestern Medical Center</institution></institution-wrap>, <city>Dallas</city>, <state>TX</state>, <country country="US">United States</country></aff><author-notes><fn id="FN1" fn-type="present-address"><label>2</label><p id="P1">Current address: Epidemiology, Biostatistics &amp; Prevention Institute, University of Zurich, Zulich, Switzerland</p></fn><fn id="FN2" fn-type="present-address"><label>3</label><p id="P2">Current address: Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland</p></fn><fn id="FN3" fn-type="present-address"><label>4</label><p id="P3">Current address: Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland</p></fn><corresp id="CR1"><bold>Correspondence</bold>: <email>hardt@micro.biol.ethz.ch</email>, <email>newsonj@ethz.ch</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>18</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>14</day><month>12</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P4"><italic>Salmonella</italic> enterica spp. rely on translocation of effector proteins through the SPI-2 encoded type III secretion system (T3SS) to achieve pathogenesis. More than 30 effectors contribute to manipulation of host cells through diverse mechanisms, but interdependency or redundancy between effectors complicates the discovery of effector phenotypes using single mutant strains. Here, we engineer six mutant strains to be deficient in cohorts of SPI-2 effector proteins, as defined by their reported function. Using various animal models of infection, we show that three principle phenotypes define the functional contribution of the SPI-2 T3SS to infection. Multimutant strains deficient for intracellular replication, for manipulation of host cell defences, or for expression of virulence plasmid effectors all showed strong attenuation <italic>in vivo</italic>, while mutants representing approximately half of the known effector complement showed phenotypes similar to the wild-type parent strain. By additionally removing the SPI-1 T3SS, we find cohorts of effector proteins that contribute to SPI-2 T3SS-driven enhancement of gut inflammation. Further, we provide an example of how iterative mutation can be used to find a minimal number of effector deletions required for attenuation, and thus establish that the SPI-2 effectors SopD2 and GtgE are critical for the promotion of gut inflammation and mucosal pathology. This strategy provides a powerful toolset for simultaneous parallel screening of all known SPI-2 effectors in a single experimental context, and further facilitates the identification of the responsible effectors, and thereby provides an efficient approach to study how individual effectors contribute to disease.</p></abstract></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P5">A common virulence strategy of Gram-negative pathogens is the use of type-three secretion systems (T3SS) to translocate bacterial effector proteins into host cells (<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>). Effectors provide a mechanism for the bacterial manipulation of host cells to produce outcomes that favour pathogenesis. <italic>Salmonella enterica</italic> serovars express two distinct T3SS encoded on the genomic regions termed <italic>Salmonella</italic>-pathogenicity island-1 and -2 (SPI-1 and SPI-2) (<xref ref-type="bibr" rid="R3">3</xref>). Collectively, effectors translocated by the SPI-1 T3SS mediate invasion into host cells and the induction of a strong inflammatory response in the gut lumen, which diminishes colonisation resistance and promotes expansion of luminal <italic>Salmonella</italic> populations, permitting robust transmission to new hosts (<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R6">6</xref>). In contrast, the SPI-2 T3SS is deployed exclusively by intracellular <italic>Salmonella</italic>, which reside within the <italic>Salmonella</italic>-containing vacuole (SCV) in both epithelial cells and phagocytic immune cells (<xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref>). SPI-2 effectors contribute to a range of phenotypes that promote intracellular replication and survival, which enables within-host migration to systemic niches and later reseeding of the gut (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R10">10</xref>). Arguably, the SPI-1 and SPI-2 T3SS together represent the principal virulence factors that mediate the pathogenic lifestyle of <italic>Salmonella</italic>, and indeed a mutant deficient for both T3SS is greatly impaired at inducing gut inflammation, and is not able to efficiently invade into nor survive within host tissue (<xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R10">10</xref>). These strong phenotypes should be attributable to the collective functions of translocated effector proteins, in addition to any effect exerted by the injection apparatuses themselves, and so it remains a central challenge to characterise the contribution of individual effectors. While most SPI-1 effectors have clear functions assigned, many SPI-2 effectors remain poorly characterised and it is not clear how individual effectors collectively contribute to the virulence phenotypes mediated by the SPI-2 T3SS.</p><p id="P6">More than 30 SPI-2 T3SS effectors have been identified for the prototypical laboratory strain <italic>S</italic>. Typhimurium SL1344. Since the discovery and characterisation of the SPI-2 T3SS (<xref ref-type="bibr" rid="R7">7</xref>, <xref ref-type="bibr" rid="R8">8</xref>), decades of research has revealed how many of these effectors function to enable SPI-2 virulence, and these efforts are well reviewed elsewhere (<xref ref-type="bibr" rid="R11">11</xref>–<xref ref-type="bibr" rid="R13">13</xref>). Briefly, SPI-2 effectors collectively contribute to a range of important intracellular activities, including the development and maintenance of the SCV, control of host cell trafficking, manipulation of cell signalling pathways that can lead to pro- or anti-inflammatory outcomes, and interference with the development of adaptive immunity (<xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R14">14</xref>). Many SPI-2 effectors are enzymes that catalyse a diverse range of biochemical post-translational modifications to host proteins, while others act in a structural manner by binding to host enzymes to cause changes in substrate specificity (<xref ref-type="bibr" rid="R12">12</xref>). The acquisition of a broad complement of effectors over evolutionary time likely contributes to the success of <italic>Salmonella enterica</italic> spp. as a broad host-range pathogen, and similarly represents a highly tuneable bacterial strategy for keeping evolutionary pace with host cell defences that restrict bacterial proliferation. Thus, the study of SPI-2 effectors is critical to understand the mechanisms underpinning bacterial subversion of host cell processes, and should inform better strategies for control of this pathogen.</p><p id="P7">However, there are significant experimental challenges to the study of individual SPI-2 effectors. Logistically, the creation and characterisation of more than 30 single mutant strains is laborious, and while this strategy has been successful in screening for SPI-2 virulence phenotypes in vitro (<xref ref-type="bibr" rid="R15">15</xref>–<xref ref-type="bibr" rid="R17">17</xref>), there are significant experimental hurdles in more complicated experimental designs, especially those using animal models of infection. Additionally, many effectors have been reported to have or are speculated to have redundant or interdependent functions. Previous studies exploring single mutant phenotypes have shown that single deletions for most effectors have no impact on intracellular replication or survival during in vitro experiments (<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R18">18</xref>). The creation of multimutant strains, in which more than one effector is deleted in a particular genetic background, has proven useful in identifying effectors that are necessary or sufficient for certain virulence phenotypes (<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R20">20</xref>). However, in many cases, the design of these multimutants precludes their use in systematically interrogating the function of all effectors in one experimental setup. Thus, there is a need for new tools that enable rapid and logistically simpler interrogation of SPI-2 effector functions, both to understand the activity of individual effectors and to explore how effectors cooperatively or redundantly contribute to broader virulence phenotypes.</p><p id="P8">Here, we describe the design and construction of six multimutant strains of <italic>S</italic>.Tm SL1344, each deficient for three to six different SPI-2 effectors, collectively covering the known repertoire of SPI-2 effectors in this genetic background. We deployed these mutant strains in several murine models of <italic>Salmonella</italic> infection and found that effector cohorts required for intracellular replication and host-cell survival were critical for expansion in systemic niches, while approximately half of the SPI-2 effector repertoire remained dispensable for virulence. Further, these same effector cohorts were also required for migration from the gut to systemic niches during oral infection. We found that deletion of two effector cohorts could ablate the onset of SPI-2 T3SS-dependent gut inflammation, in the absence of SPI-1 T3SS effector translocation. Finally, we demonstrate a strategy for identifying the individual effectors that contribute to a cohort phenotype by use of simpler mutant strains, and thus describe an unreported role for the effectors SopD2 and GtgE in driving gut inflammation. Together, we show how complex multimutants can be deployed to interrogate virulence phenotypes, a strategy which should be broadly applicable in different experimental contexts.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Construction and validation of SPI-2 effector multimutant strains</title><p id="P9">To surmount the experimental difficulties in studying how individual SPI-2 effectors contribute to various SPI-2 T3SS-mediated phenotypes, we designed and constructed a set of six multimutant strains in the <italic>Salmonella</italic> Typhimurium (<italic>S</italic>. Tm) SL1344 background. The design of these strains was guided by several criteria: effectors that contribute to similar phenotypes based on their reported functions should be deleted together; each effector should only be deleted once across all six strains; intergenic regions between closely located effectors should be preserved; and effectors should be removed as single deletions where possible, rather than deleting multiple closely-located effectors. The characterisation of SPI-2 effectors has been a priority since the identification and characterisation of the SPI-2 T3SS several decades ago, and thus the depth of literature available permits the loose grouping of effectors into functional groups (<xref ref-type="fig" rid="F1">Fig. 1A</xref>). This informed the design of multimutant strains lacking effectors that could reasonably be deleted to produce a strain deficient for a particular function (e.g. a strain lacking several key effectors contributing to development and maintenance of the <italic>Salmonella</italic>-containing vacuole). Some effectors remain poorly characterized with no reported function or host targets, and these were similarly grouped as a multimutant strain. Finally, we used a single mutant deletion for <italic>spvR</italic> to represent a functional deletion of the virulence plasmid-encoded effectors <italic>spvB, spvC</italic>, and <italic>spvD</italic>, in line with previous work (<xref ref-type="bibr" rid="R15">15</xref>).</p><p id="P10">The workflow for generating multimutant strains (<xref ref-type="fig" rid="F1">Fig. 1B</xref>) involved the initial construction of single-mutant strains representing all known SL1344 SPI-2 effectors, either by lambda red recombinase-mediated replacement of target genes with antibiotic resistance cassettes, or by leveraging an existing library of single mutant strains constructed in an <italic>S</italic>.Tm 14028S background. These single mutant strains were then used to generate P22 lysates which contained randomly-packaged segments of the bacterial chromosome. Using this library of P22 lysates, we sequentially performed P22 transduction to introduce these gene deletions into a clean SL1344 background, followed by Flp-FRT-mediated removal of resistance cassettes. This process was repeated to sequentially delete up to six genes from an individual strain, and we performed this process in duplicate to generate two independent clone of each multimutant strain. Ultimately, we constructed six multimutant strains covering broad functional groups of <italic>Salmonella</italic> virulence, and assigned these strains designations based on the first six letters of the Greek alphabet (<xref ref-type="fig" rid="F1">Fig. 1C</xref>). We performed whole-genome sequencing to validate the construction of these multimutant strains, and to determine the degree of unwanted changes to the chromosome of these strains (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). This analysis confirmed that all strains bear the correct deletion based on the intended design, and are thus suitable for experimental use. We detected a number of polymorphisms that likely arose due to successive genetic manipulation and passaging in laboratory conditions, which seemed to loosely correlate to the number of genes deleted in each strain (<italic>i.e</italic>. strains with six deletions tended to bear more polymorphisms than those with four) (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). Other polymorphisms are a consequence of transducing genes that were originally deleted in the <italic>S</italic>. Tm 14028 background and transferred to the SL1344 genome (<italic>i.e</italic>. naturally occurring differences in the SL1344 and 14028 genomes) and these are annotated in <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>. We observed distinct polymorphisms arising between two independently constructed clones of each multimutant, suggesting these genetic changes arise randomly during the construction process. This also provides the opportunity to compare the fitness of each clone, to establish whether particular virulence phenotypes may be attributable to these unwanted polymorphisms. Finally, we observed no significant genomic rearrangement or other changes to the genome, including the presence or absence of phages or other mobile elements.</p><p id="P11">Thus, we report the correct construction of six SPI-2 effector multimutant strains that are suitable for use in various experimental contexts and should be useful in advancing the study of individual and collective SPI-2 effector-mediated phenotypes.</p></sec><sec id="S4"><title>SPI-2 effector cohorts contribute to systemic infection <italic>in vivo</italic></title><p id="P12">Next, we aimed to characterise the phenotypes of these multimutant strains in an infection context, and thus describe how different effector cohorts contribute to virulence. We infected C57BL/6 mice with 10<sup>3</sup> <italic>S</italic>. Tm by intraperitoneal injection (<xref ref-type="fig" rid="F2">Fig 2A</xref>), which is a well-established murine model of systemic infection that is characterised by high levels of bacterial replication in systemic niches such as the spleen and liver (<xref ref-type="bibr" rid="R21">21</xref>, <xref ref-type="bibr" rid="R22">22</xref>). At day 4 post infection (<xref ref-type="fig" rid="F2">Fig 2B</xref>), we observed very high bacterial loads in the liver (left) and spleen (right) of mice infected with <italic>S</italic>.Tm WT, while mice infected with <italic>S</italic>.Tm Δ<italic>ssaV</italic> (deficient for assembly of the SPI-2 T3SS) or <italic>S</italic>.Tm Efl (deficient for all known SPI-2 effectors (<xref ref-type="bibr" rid="R15">15</xref>)) had greatly reduced bacterial loads, consistent with the critical role played by the SPI-2 T3SS in mediating intracellular replication and survival. Of the six multimutant strains, we observed a significant reduction in bacterial loads in mice infected with <italic>S</italic>.Tm Alpha, Delta, and Zeta, suggesting the effector groups deleted here play important roles in systemic infection. Surprisingly, three multimutant strains – <italic>S</italic>.Tm Beta, Gamma, and Epsilon – showed bacterial loads to the WT in both liver and spleen, suggesting these effectors are not required for virulence under these conditions. Further, we observed a similar trend in bacterial numbers in the mesenteric lymph node (<xref ref-type="supplementary-material" rid="SD1">Fig S1A, left</xref>), suggesting these effectors play similar roles in colonisation of this site, while colonisation of the gut showed a less clear trend but nonetheless suggests the SPI-2 T3SS is important for delayed gut colonisation, consistent with previous findings (<xref ref-type="supplementary-material" rid="SD1">Fig S1A, right</xref>). To determine if these strong phenotypes arise as a result of bacterial replication and survival, or if these differences are attributable to an initial failure to successfully colonise these sites, we repeated these experiments but euthanised mice at day 2 post infection. We observed a broadly similar trend at this earlier stage of infection (<xref ref-type="supplementary-material" rid="SD1">Fig S1B</xref>) compared to later stages (<xref ref-type="fig" rid="F2">Fig 2B</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S1A</xref>), which suggests that while these functional cohorts do play distinct roles at early stages, the contribution of these effectors to virulence becomes significantly more pronounced as the systemic infection progresses. Collectively, the systemic infection phenotypes of our SPI-2 effector multimutants are broadly concordant with the reported function of <italic>S</italic>. Tm mutants lacking individual effectors, and so the multimutant phenotypes can be interpreted as compound phenotypes that emerge from the successive deletion of effectors in a given multimutant. Thus, our set of multimutants can provide an efficient means to survey which SPI-2 effectors contribute to a particular virulence phenotype.</p><p id="P13">A common strategy for studying virulence phenotypes is to perform competitive index experiments, in which a mixed inoculum comprising both the mutant strain and the wild-type strain is used for infection. In animal models of infection, the testing of multiple strains in the same mouse reduces the number of animals required for the analysis, and provides internal controls for animal-specific differences in disease progression. To enable this approach using our multimutant strains, we introduced a unique fitness-neutral genetic tag into each strain (<xref ref-type="bibr" rid="R23">23</xref>), alongside the control strains <italic>S</italic>.Tm WT, <italic>S</italic>.Tm Δ<italic>ssaV</italic>, and <italic>S</italic>.Tm Efl. These tags can be quantified with a very high signal-to-noise ratio (greater than 1:100 000), either by quantitative RT-PCR or by a sequence counting utilising PCR amplification and next generation sequencing (<xref ref-type="bibr" rid="R24">24</xref>). The resulting collection of 9 tagged strains was then used to infect C57BL/6 mice by i.p. infection (<xref ref-type="fig" rid="F2">Fig 2C</xref>) to assay the relative fitness of each strain within a single animal. We observed a similar trend as for single infection (<xref ref-type="fig" rid="F2">Fig 2B</xref>) in these mixed infection experiments (<xref ref-type="fig" rid="F2">Fig 2D</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S1C-D</xref>), in which <italic>S</italic>.Tm WT, <italic>S</italic>.Tm Beta, <italic>S</italic>.Tm Gamma, and <italic>S</italic>.Tm Epsilon greatly outcompeted <italic>S</italic>.Tm Δ<italic>ssaV, S</italic>.Tm Efl, and the mutant strains <italic>S</italic>.Tm Alpha, <italic>S</italic>.Tm Delta, and <italic>S</italic>.Tm Zeta. These data suggest the deficiencies of effector deletion strains cannot be compensated for by the presence of <italic>S</italic>.Tm WT or other mutants bearing WT-copies of effector genes within the same host animal. As we observed similar phenotypes during single and mixed infection, a mixed inoculum could therefore be used to screen for virulence phenotypes in other experimental contexts in a relatively higher-throughput and logistically simpler manner.</p></sec><sec id="S5"><title>Virulence-dependent migration from the gut to systemic niches</title><p id="P14">Oral infection represents the natural route of <italic>Salmonella</italic> infection in mice and other animals, and is characterised by invasion into epithelial tissue and induction of a strong inflammatory response in the gut lumen, followed by migration to systemic sites like the spleen and liver which serve as a niche for bacterial replication (<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R25">25</xref>). While the SPI-1 T3SS is the principal virulence factor that mediates gut infection, the SPI-2 T3SS also plays important roles in the colonisation of the lamina propria and a delayed but potent induction of gut inflammation (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R26">26</xref>). Similarly, there is a strong requirement for SPI-2 T3SS activity in order for <italic>S</italic>.Tm to reach systemic niches beyond the gut. To explore how particular SPI-2 effectors might contribute to these phenotypes, we infected mice (<xref ref-type="fig" rid="F3">Fig 3A</xref>) using the well-established streptomycin pretreatment model of oral infection (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R27">27</xref>). By day 4 post infection, <italic>S</italic>.Tm WT had colonised (<xref ref-type="fig" rid="F3">Fig 3B</xref>) both the liver (left) and spleen (right) and replicated to high numbers, while both <italic>S</italic>.Tm Δ<italic>ssaV</italic> and <italic>S</italic>.Tm Efl were recovered either at very low numbers or not at all, indicating a strong reliance on SPI-2 T3SS virulence for invasive infection of systemic niches. We observed lower population sizes in mice infected with either <italic>S</italic>.Tm Alpha or <italic>S</italic>.Tm Zeta, while <italic>S</italic>.Tm Delta showed an especially pronounced reduction in bacterial load, similar to that observed for <italic>S</italic>.Tm Δ<italic>ssaV</italic> and <italic>S</italic>.Tm Efl. In the mesenteric lymph node (<xref ref-type="fig" rid="F3">Fig 3C</xref>), we observed similar colonisation for all strains with modestly reduced CFU for <italic>S</italic>.Tm Δ<italic>ssaV</italic> and <italic>S</italic>.Tm WT Delta. Similarly, we recovered similar numbers in the faeces (<xref ref-type="fig" rid="F3">Fig 3D</xref>) of mice infected with each strain, indicating no significant contribution to gut luminal populations as expected for this model (<xref ref-type="bibr" rid="R10">10</xref>). Finally, we measured enteropathy in the cecum tissue and observed a broadly similar degree of pathology in all mice (<xref ref-type="fig" rid="F3">Fig 3E-F</xref>). While this may suggest a limited contribution of SPI-2 effectors to gut pathology, it seems more likely that the strong pathology induced by the SPI-1 T3SS (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R27">27</xref>) masks more subtle contributions by SPI-2 effectors. Overall, these data suggest that while there are minimal differences in gut colonisation and tissue pathology between multimutant strains, the subsequent migration to systemic niches followed by intracellular replication and survival is strongly dependent on particular cohorts of SPI-2 effectors, while others remain surprisingly dispensable.</p></sec><sec id="S6"><title>Induction of SPI-2 T3SS-driven gut inflammation requires cohorts of effectors</title><p id="P15">Using our SPI-2 multimutant strains, we observed relatively little difference in the induction of enteropathy in the cecal tissue (<xref ref-type="fig" rid="F3">Fig 3E-F</xref>), which is a hallmark of oral infection in mice and driven largely by the SPI-1 T3SS. We speculated that more subtle contributions of SPI-2 effectors to gut infection, particularly the delayed onset of inflammation, might be masked by the activity of SPI-1 effectors. To explore this, we created a set of SPI-2 multimutant strains that is additionally deficient for SPI-1 T3SS effector translocation by deleting <italic>invG</italic>, encoding a key structural component of the SPI-1 T3SS (<xref ref-type="bibr" rid="R28">28</xref>). Thus, these strains are deficient for SPI-1 effector translocation and additionally lack genes for distinct cohorts of SPI-2 effectors, as in <xref ref-type="fig" rid="F1">Fig 1C</xref>.</p><p id="P16">These tools allow for the elucidation of subtle phenotypes that are otherwise undetectable against the severe gut pathology induced by SPI-1 effectors. We performed oral infection in streptomycin pre-treated mice as previously (<xref ref-type="fig" rid="F3">Fig 3A</xref>) and observed that both WT and <italic>S</italic>.Tm Δ<italic>invG</italic> are recovered at similar numbers in the liver, spleen, and mesenteric lymph node by day 4 post infection, consistent with previous work (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R27">27</xref>). Concordantly, there was little difference in CFU recovered for <italic>invG</italic>-deficient multimutants at these sites (<xref ref-type="fig" rid="F4">Fig 4A</xref>) compared to the respective <italic>invG</italic>-competent strains (<xref ref-type="fig" rid="F3">Fig 3B-C</xref>). This suggests that SPI-2 remains the primary virulence factor mediating colonisation of systemic sites. By day 4 post infection, we observed a trend towards reduced faecal loads for <italic>S</italic>.Tm Δ<italic>invGΔssaV</italic> (deficient for both SPI-1 and SPI-2 T3SS assembly), consistent with previous reports (<xref ref-type="bibr" rid="R29">29</xref>). Interestingly, a similar trend was observed for all <italic>invG</italic>-deficient multimutants (<xref ref-type="fig" rid="F4">Fig 4B</xref>), perhaps suggesting previously unidentified roles for diverse SPI-2 T3SS effectors in the prolongation of <italic>S</italic>.Tm gut colonisation.</p><p id="P17">Induction of gut inflammation mediated by the SPI-1 T3SS is a well-established hallmark of infection in the streptomycin pre-treatment model, while SPI-1 mutants cause delayed but significant inflammation in a SPI-2 T3SS-dependent manner (<xref ref-type="bibr" rid="R26">26</xref>). While the mechanisms of SPI-2 driven inflammation remain enigmatic, this delayed inflammation has been linked to prolonged <italic>S</italic>.Tm gut colonisation (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R29">29</xref>–<xref ref-type="bibr" rid="R31">31</xref>). Here, we also observed a gradual but strong increase in gut inflammation in the <italic>S</italic>.Tm Δ<italic>invG</italic> strain (thus caused by SPI-2 effectors), while <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>ssaV</italic> strain fails to induce gut inflammation, as expected (<xref ref-type="fig" rid="F4">Fig 4C</xref>). For most <italic>invG</italic>-deficient multimutants we observed a similar trend in which initially uninflamed conditions in the gut gave rise to potent inflammation by day 4 post infection, based on lipocalin-2 ELISA. However, we noted a previously unappreciated trend in which no multimutant produced inflammation to the degree of the SPI-1 or SPI-2 competent strains, which may suggest that diverse perturbations of the SPI-2 effector complement can disrupt the induction of gut inflammation. Regardless, we observed particularly strong phenotypes for <italic>S</italic>.Tm Alpha and <italic>S</italic>.Tm Delta, which showed inflammation profiles similar to that of <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>ssaV</italic> and greatly diminished relative to <italic>S</italic>.Tm WT (<xref ref-type="fig" rid="F4">Fig 4C</xref>). To further explore the contributions to gut pathology, we repeated our examination of cecal pathology in these mice (<xref ref-type="fig" rid="F4">Fig 4D-E</xref>). Here, we observed that both <italic>S</italic>.Tm Δ<italic>invG</italic> and <italic>S</italic>.Tm Δ<italic>ssaV</italic> could produce enteropathy that contributes to the strong level of disease seen in <italic>S</italic>.Tm WT-infected mice, while mice infected with <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>ssaV</italic> retained relatively healthy gut tissue. This healthy state was phenocopied by both <italic>S</italic>.Tm <italic>invG</italic> Alpha and <italic>S</italic>.Tm <italic>invG</italic> Delta, suggesting that in the absence of the SPI-1 T3SS these effector cohorts contribute to potent SPI-2-dependent gut inflammation and pathology. All other <italic>invG</italic>-deficient multimutants produced enteropathy approaching that of the control strains, indicating a dispensability of the induction of gut pathology. Together, these data provide initial mechanistic insights into how SPI-2 effectors can contribute to delayed but significant inflammatory phenotypes in the intestinal mucosa.</p></sec><sec id="S7"><title>Iterative deletion of effector genes reveals individual SPI-2 effectors required for gut inflammation</title><p id="P18">As described in <xref ref-type="fig" rid="F1">Fig 1C</xref>, the multimutant strains were constructed via sequential deletion of individual effector genes. Thus, the creation of a six-fold mutant required the preceding construction of the parent five-fold mutant, and before that a four-fold mutant, <italic>et cetera</italic>. Each stepwise mutant was preserved in cryostorage, and thus it is possible to use these simpler mutants to determine which particular genes may contribute to the phenotype observed for the complete multimutant. To provide an example of this strategy, we chose to focus on the <italic>S</italic>.Tm Delta strain, which we showed was deficient for colonisation of systemic niches during intraperitoneal infection (<xref ref-type="fig" rid="F2">Fig 2</xref>), and showed pronounced attenuation for migration from the gut to these systemic niches in oral infection (<xref ref-type="fig" rid="F3">Fig 3</xref>), and was ultimately shown to contribute to SPI-2-dependent gut inflammation and enteropathy (<xref ref-type="fig" rid="F4">Fig 4</xref>). The <italic>S</italic>.Tm Delta mutant comprises deletions in four effector genes: <italic>steC, sseL, sopD2</italic>, and <italic>gtgE</italic>. To determine which effectors contribute to the strong phenotype observed for this multimutant, we used the Δ<italic>steC</italic>Δ<italic>sseL</italic> double mutant created during the stepwise construction of <italic>S</italic>.Tm Delta, and separately constructed a Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> double mutant. We infected mice by oral gavage as previously (<xref ref-type="fig" rid="F3">Fig 3A</xref>), and observed that <italic>S</italic>.Tm Δ<italic>steC</italic>Δ<italic>sseL</italic> phenocopied <italic>S</italic>.Tm WT, while the Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> double mutant was recovered in similar numbers to <italic>S</italic>.Tm Δ<italic>ssaV</italic> (<xref ref-type="fig" rid="F5">Fig 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S2A</xref>), and thus these two effectors alone mediate the <italic>S</italic>.Tm Delta phenotypes. We next used single mutants to determine the relative contribution of each individual effector, and found only partial reductions relative to the WT, demonstrating that both effectors must be deleted together to produce this phenotype, likely due to the functional overlap between these effectors. Finally, we complemented the Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> double mutant by sequential chromosomal restoration of WT copies of these genes, and found that the double-complemented Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> mutant was restored to approximately WT levels in this infection model (<xref ref-type="fig" rid="F5">Fig 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S2A</xref>). Thus, we demonstrate how complex multimutant phenotypes can be interrogated by characterising simpler mutants in a deductive manner,</p><p id="P19">Previous work has described how SopD2 and GtgE are critical for systemic proliferation following intraperitoneal injection of mice (<xref ref-type="bibr" rid="R32">32</xref>), but the contributions of these effectors to gut pathology remains unexplored. Here, we established that gut inflammation during oral infection could be ablated by deletion of both the SPI-1 T3SS and certain cohorts of SPI-2 effectors, including those deficient in <italic>S</italic>.Tm Delta (<xref ref-type="fig" rid="F4">Fig 4D-E</xref>). Given that deletion of <italic>sopD2</italic> and <italic>gtgE</italic> was sufficient to phenocopy <italic>S</italic>.Tm Delta in terms of systemic colonisation (<xref ref-type="fig" rid="F5">Fig 5A</xref>), we hypothesised that deletion of these two effectors and the SPI-1 T3SS would similarly be sufficient to reduce gut inflammation to levels seen for the avirulent <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>ssaV</italic>. To explore this, we deleted <italic>invG</italic> from the double mutant <italic>S</italic>.Tm Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> and orally infected mice as previously (<xref ref-type="fig" rid="F3">Fig 3A</xref>). Indeed, while a triple mutant <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> failed to successfully colonise the liver, spleen, and mesenteric lymph nodes in a manner similar to the double mutant <italic>S</italic>.Tm Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> (<xref ref-type="fig" rid="F5">Fig 5B</xref>), there was a marked decrease in gut inflammation whereby the triple mutant failed to induce both early and late stage inflammation, similar to levels seen for the avirulent Δ<italic>invG</italic>Δ<italic>ssaV</italic> strain (<xref ref-type="fig" rid="F5">Fig 5C</xref>, <xref ref-type="supplementary-material" rid="SD1">Fig S2B</xref>).</p><p id="P20">Intracellular reservoirs of <italic>S</italic>.Tm residing in the cecal tissue can contribute to sustained gut pathology (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R33">33</xref>). We performed a gentamycin protection assay on infected mucosal tissue (<xref ref-type="bibr" rid="R34">34</xref>) to determine the contribution of SopD2 and GtgE to survival of intracellular <italic>S</italic>.Tm within cecal tissue. Here, we recovered fewer <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> and <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>ssaV</italic> relative to <italic>S</italic>.Tm WT (<xref ref-type="fig" rid="F5">Fig 5D</xref>), perhaps suggesting local replication and survival in cecal tissue is important for sustained gut inflammation. Finally, we discovered a corresponding ablation of enteropathy in the cecum of mice infected with either <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> or Δ<italic>invG</italic>Δ<italic>ssaV</italic>, confirming that deletion of these two SPI-2 effectors is sufficient for ablation of SPI-2 T3SS-dependent gut inflammation (<xref ref-type="fig" rid="F5">Fig 5E-F</xref>). Collectively, these data provide new mechanistic insights into how specific SPI-2 effectors contribute to inflammatory outcomes in the infected gut, and provide a proof of concept for how strong phenotypes observed using <italic>S</italic>.Tm effector multimutant strains can be rapidly narrowed to candidate effectors responsible for this activity (<xref ref-type="fig" rid="F6">Fig 6</xref>).</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P21">The intracellular lifestyle of pathogenic <italic>Salmonella enterica</italic> spp. is driven by the activity of SPI-2 T3SS effectors, but efforts to characterise the function of individual effectors have proven complicated, either by instances of interdependency or redundancy between effectors, or by the logistical difficulties in characterising more than 30 proteins across different experimental contexts. Here, we designed SPI-2 effector multimutants to explore which effector cohorts are critical for pathogenesis in a logistically easier manner, and showed how such tools can be used to find a minimal set of effectors responsible for key phenotypes, using SPI-2-dependent promotion of gut inflammation as an example.</p><p id="P22">In designing and constructing SPI-2 effector multimutants, we loosely grouped effectors that reportedly contribute to similar functions. For example, the six effectors deleted in <italic>S</italic>.Tm Alpha (<italic>sseF, sseG, sifA, sseJ, pipB2, steA</italic>) collectively contribute to development and maintenance of the SCV, while <italic>S</italic>.Tm Beta is deficient for six effectors (<italic>sseK1, sseK2, sseK3, gtgA, gogA, pipA</italic>) that antagonise different aspects of host cell signalling pathways. The rational grouping of deletions is dependent on the reported function of each effector (<xref ref-type="fig" rid="F1">Fig 1A</xref>), and many effectors have functions that are unknown or disputed. Thus, it is possible that unreported functions or inter-effector relationships may contribute to phenotypes that are masked by the current design. Similarly, undiscovered effectors likely exist and the activity of those effectors may contribute to shared phenotypes. While we observed strong phenotypes for several multimutants (<italic>S</italic>.Tm Alpha, Delta, and Zeta), other mutants (<italic>S</italic>.Tm Beta, Gamma, and Epsilon) representing approximately half of the known SL1344 effector repertoire phenocopied <italic>S</italic>.Tm WT in different infection models. It is possible that these effectors do have phenotypes in other infection models (e.g. in a different host species, or during chronic infection), or that the impact is too subtle to measure via the methods used here. Ultimately, further careful characterisation of these mutants in different infectious contexts and using different methodology will be useful to fully characterise the role of these effectors. An alternative explanation for the lack of strong phenotypes for several mutants tested here is the context-dependency of deletion mutants, described elsewhere as the effector network hypothesis (<xref ref-type="bibr" rid="R35">35</xref>–<xref ref-type="bibr" rid="R37">37</xref>). Effectors of the gut pathogen <italic>Citrobacter rodentium</italic> reportedly form robust networks that can tolerate the loss of a number of effectors, but deletion of an increasingly large number of effectors ultimately causes a collapse of virulence phenotypes back to an avirulent level. Importantly, this same study describes context-dependent essentiality of effectors, in which deletion of a single effector may or may not produce a strong phenotype depending on the availability of other effectors (<xref ref-type="bibr" rid="R35">35</xref>). Certainly this possibility may also exist for the effector cohort of <italic>S</italic>.Typhimurium, and this may complicate the comparison of studies such as ours with previous and future work.</p><p id="P23">Other studies have employed the strategy of sequentially deleting multiple genes encoding effector proteins, though the design and rationale for these efforts varies. Chen <italic>et al</italic> (<xref ref-type="bibr" rid="R15">15</xref>) iteratively deleted the majority of known SPI-2 effectors in a single genetic background, producing an ‘effectorless’ <italic>S</italic>. Tm SL1344 derivative that is otherwise competent for SPI-2 T3SS assembly and function. Restoring selected effectors to this effectorless strain by complementation allowed for the identification of a ‘minimal network’ of effectors that was sufficient for virulence during oral infection <italic>(sifA</italic>, <italic>sseFG</italic>, <italic>steA</italic>, <italic>sopD2</italic>, and <italic>spvBCD</italic>) (<xref ref-type="bibr" rid="R15">15</xref>). Elsewhere, separate studies have focused on deleting core sets of effectors to produce a strain that is reduced to Δ<italic>ssaV</italic>-levels of virulence. Strong phenotypes have thus been reported for a seven-fold deletion strain (<italic>S</italic>.Tm Δ<italic>sseF</italic> Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sopD2</italic> Δ<italic>sseJ</italic> Δ<italic>steA</italic> Δ<italic>pipB2</italic>) (<xref ref-type="bibr" rid="R19">19</xref>), and separately for a five-fold deletion (<italic>S</italic>.Tm Δ<italic>sifA</italic> Δ<italic>spvB</italic> Δ<italic>sseF</italic> Δ<italic>sseJ</italic> Δ<italic>steA</italic>, created in a SPI-1 T3SS-deficient background) (<xref ref-type="bibr" rid="R20">20</xref>). These efforts represent important steps in understanding how individual effectors contribute to strong collective phenotypes, but they are less useful in contexts where screening for individual effectors is important. The advantage of our strategy described here is that the activity of all effectors can be explored in a single experimental context, and responsible effectors can subsequently be identified by use of simpler mutants. We anticipate that these multimutant strains could be used to screen for SPI-2 T3SS effector functions in other experimental contexts and infection models, for example to study chronic carriage in genetically resistant mice, intracellular replication <italic>in vitro</italic> in various host cell types, virulence phenotypes in various genetically-modified mouse backgrounds, or performance in reporter assays that measure cell signalling outcomes.</p><p id="P24">Our work highlights the strong contribution of SopD2 and GtgE to virulence in both oral and systemic infection. The molecular target of both of these effectors is the host GTPase Rab32 (<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R38">38</xref>), which restricts intracellular bacteria via its nucleotide exchange factor BLOC-3 (<xref ref-type="bibr" rid="R39">39</xref>). The acquisition of SopD2 and GtgE by <italic>S</italic>.Typhimurium permits the complementary antagonism of Rab32, in which SopD2 functions as a GAP mimic to limit Rab32 GTPase activity, while GtgE directly proteolytically cleaves Rab32 (<xref ref-type="bibr" rid="R32">32</xref>, <xref ref-type="bibr" rid="R38">38</xref>). In the absence of these effectors, Rab32 and the co-factor BLOC-3 facilitate the delivery of itaconate to the SCV (<xref ref-type="bibr" rid="R40">40</xref>, <xref ref-type="bibr" rid="R41">41</xref>), which restricts intravacuolar <italic>S</italic>.Tm by metabolic disruption of the glyoxylate shunt and thereby reduces bacterial replication (<xref ref-type="bibr" rid="R42">42</xref>). Thus, effector-mediated disruption of the Rab32-BLOC-3-itaconate axis represents an important strategy for the success of intracellular <italic>S</italic>.Tm populations. While it had been established that SopD2 and GtgE were important for promoting intracellular survival in systemic niches (<xref ref-type="bibr" rid="R32">32</xref>), the contributions of these effectors to gut pathology and inflammation remained unknown.</p><p id="P25">Here, we show that <italic>S</italic>.Tm Delta and <italic>S</italic>.Tm Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> cannot reach systemic niches following oral infection (<xref ref-type="fig" rid="F3">Fig 3</xref>), and this mutant also show severe attenuation in systemic sites during intraperitoneal infection (<xref ref-type="fig" rid="F2">Fig 2</xref>), similar to <italic>S</italic>.Tm Δ<italic>ssaV</italic> (<xref ref-type="bibr" rid="R10">10</xref>, <xref ref-type="bibr" rid="R26">26</xref>). Given that itaconate-mediated disruption of intracellular <italic>S</italic>.Tm restricts actively replicating bacteria (<xref ref-type="bibr" rid="R42">42</xref>), this may suggest that bacterial replication is an important activity for successful migration from the gut to systemic niches, or that cell-intrinsic host defenses impose particularly stringent control of intracellular bacteria during these migration events or during subsequent bacterial growth in systemic niches. Importantly, our current work extends previous knowledge by discovering a previously unknown function of SopD2 and GtgE in eliciting mucosal inflammation in a SPI-1 T3SS-deficient background (<xref ref-type="fig" rid="F4">Fig 4C-E</xref>, <xref ref-type="fig" rid="F5">Fig 5B-F</xref>). This finding will enable future work at molecular and cellular scales to explore why the <italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>sopD2</italic>Δ<italic>gtgE</italic> mutant is drastically impaired at inducing gut inflammation (<xref ref-type="fig" rid="F5">Fig 5C, Fig 5E-F</xref>). It may be that a reduction of bacterial numbers in the gut tissue causes a corresponding impairment of gut inflammation, but we observed only a modest reduction in CFU in the mesenteric lymph node (<xref ref-type="fig" rid="F5">Fig 5B</xref>) and faeces (<xref ref-type="supplementary-material" rid="SD1">Fig S2B</xref>), and similarly a slight reduction in the intracellular population within caecal tissue (<xref ref-type="fig" rid="F5">Fig 5D</xref>). Future work should focus on the molecular mechanisms that underpin how SopD2 and GtgE promote <italic>S</italic>. Tm growth and survival in the gut, on how this affects inflammation and mucosal pathology, and on how host cell defences (<italic>e.g</italic>. itaconate) prevent pathogen migration to systemic sites.</p><p id="P26">While we observed the strongest deficiency for <italic>S</italic>.Tm Delta, we also found that both <italic>S</italic>.Tm Alpha and <italic>S</italic>.Tm Zeta were significantly reduced in the liver and spleen during both oral (<xref ref-type="fig" rid="F3">Fig 3</xref>) and systemic infection models (<xref ref-type="fig" rid="F2">Fig 2</xref>). We observed that <italic>S</italic>.Tm Alpha colonised these sites at approximately <italic>S</italic>.Tm Δ<italic>ssaV</italic> levels by day 2 post infection, then increased modestly in the following days, suggesting this mutant can still replicate intracellularly to some extent, despite lacking the principal effectors mediating SCV maturation and expansion. Alternatively, it may be possible that this increase is attributable to extra-vacuolar or extracellular replication, or to cell-to-cell spread via efferocytosis or simply bacterial egress and reinvasion (<xref ref-type="bibr" rid="R43">43</xref>–<xref ref-type="bibr" rid="R45">45</xref>). Future work, especially using <italic>in vitro</italic> models of infection, will be useful to determine the replicative defect of this strain. We observed that <italic>S</italic>.Tm Alpha Δ<italic>invG</italic> was greatly attenuated at inducing mucosal inflammation by day 4 post infection, similar to S.Tm Delta Δ<italic>invG</italic>, and this is consistent with previous work linking some of these effectors to gut inflammation (<xref ref-type="bibr" rid="R20">20</xref>). Future work is needed to understand which minimal subset of effectors contribute to this activity, and to understand how effectors responsible for intracellular replication contribute to the induction of gut inflammation. Separately, we observed a similarly strong phenotype for <italic>S</italic>.Tm Zeta, which is deficient for the regulator SpvR and thus impaired for expression of genes on the virulence plasmid regulon <italic>spvABCD</italic> (<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>). Effectors on this operon reportedly have a range of functions: SpvB is an ADP-ribosyltransferase which causes disruption to the host cytoskeleton and also promotes cell death via apoptosis (<xref ref-type="bibr" rid="R48">48</xref>–<xref ref-type="bibr" rid="R50">50</xref>); SpvC has anti-inflammatory functions via its phosphothreonine lyase activity against several MAPK signalling proteins (<xref ref-type="bibr" rid="R51">51</xref>–<xref ref-type="bibr" rid="R53">53</xref>); while SpvD acts as a cysteine protease to inhibit NF-kB signalling, possibly by targeting host exportin Xpo2 (<xref ref-type="bibr" rid="R54">54</xref>, <xref ref-type="bibr" rid="R55">55</xref>). In this study, we show that <italic>S</italic>.Tm Zeta is strongly attenuated at colonising systemic niches but remains competent for inducing SPI-2 T3SS-dependent gut inflammation, which suggests these activities are not necessarily linked, but further work is needed to understand how the reported molecular activities of these proteins contributes to these disease phenotypes.</p><p id="P27">In conclusion, we describe how multimutants created by sequential deletion of functionally linked genes can be easily used in a variety of experimental contexts to gain new insights into bacterial virulence. We show that effector cohorts linked to intracellular replication and protection from host cell defenses are important for migration from the gut to systemic niches, and these same cohorts also contribute to SPI-2 T3SS-dependent gut inflammation. Finally, we show that the effectors SopD2 and GtgE together are necessary for these phenotypes, providing new insights into how the SPI-2 T3SS contributes to gut infection and migration within the host. We anticipate that these multimutants will prove useful in other experimental contexts to provide new insights into bacterial virulence strategies.</p></sec><sec id="S9" sec-type="methods"><title>Methods</title><sec id="S10"><title>Strains used in this study</title><p id="P28">All bacterial strains used in this study were <italic>S</italic>. Tm SL1344 SB300 (<xref ref-type="bibr" rid="R56">56</xref>) or derivatives and are listed in <xref ref-type="table" rid="T1">Table 1</xref>. Strains in cryostorage at -80 °C were streaked to selective media and subsequently used to inoculate overnight cultures comprising lysogeny broth (LB) medium containing appropriate antibiotics (50 μg/ml streptomycin, 50 μg/ml ampicillin, 50 μg/ml kanamycin, or 15 μg/ml chloramphenicol, as required).</p></sec><sec id="S11"><title>Strain construction</title><p id="P29">All primers used for strain construction and validation are listed in <xref ref-type="table" rid="T2">Table 2</xref>. Single mutant strains were constructed using the lambda-red protocol, in which a gene of interest is replaced with an antibiotic resistance cassette flanked by FRT sites (<xref ref-type="bibr" rid="R57">57</xref>). Primers were designed with approximately 40 base pairs flanking the gene of interest and 20 base pairs of an antibiotic resistance cassette. Plasmids pKD3 or pKD4 were used as DNA templates in PCR reactions to amplify products suitable for gene replacement with cassettes encoding chloramphenicol (pKD3) or kanamycin (pKD4) resistance via homologous recombination. <italic>S</italic>.Tm SL1344 carrying the plasmid pKD46 was incubated for 3 hours at 30 °C in LB containing 50 μg/ml ampicillin and 10 mM arabinose. Cells were washed in ice cold water and concentrated via centrifugation, then transformed with purified DNA via electroporation. Cells were let to recover in LB for 1 hour at 37°C, then plated to LB agar plates containing either 50 μg/ml kanamycin or 15 μg/ml chloramphenicol, as required. Colonies were picked and genotyped via PCR with primers flanking the replaced gene of interest. P22 lysates were generated from these mutant strains, and used to transfer the deletion of interest to a clean strain of <italic>S</italic>.Tm SL1344, which was subsequently passaged via replating several times to promote clearance of phage and regenotyped via PCR. Multimutants were similarly constructed by repeated rounds of P22 transduction as above. Strains bearing both chloramphenicol and kanamycin resistance (<italic>i.e</italic>. after two rounds of P22 transduction) had these resistance cassettes removed via electroporation with pCP20 encoding the <italic>Flp</italic> recombinase flippase. All strains were regenotyped after each round of Flp-FRT recombination, to avoid unwanted recombination events at FRT scar sites.</p></sec><sec id="S12"><title>Chromosomal complementation of effector genes</title><p id="P30">Mutant strains deficient for <italic>sopD2</italic> and <italic>gtgE</italic> were complemented with these genes via subcloning into a suicide vector followed by conjugation and homologous recombination into recipient strains. Briefly, PCR was used to generate amplicons comprising either <italic>sopD2</italic> or <italic>gtgE</italic> with 1000 bp flanking regions and suitable restriction sites. Amplicons were cloned into vector pSB890 via T4 DNA ligase reactions, then used to transform electrocompetent <italic>E. coli</italic> SM10λpir. Overnight cultures of recipient strains were prepared, then combined with cultures of donor strains. Selection with sucrose and tetracycline was used to identify successful conjugation and recombination events, which were confirmed by genotyping PCR.</p></sec><sec id="S13"><title>Whole-genome sequencing and bioinformatics analysis</title><p id="P31">Overnight cultures of multimutant strains were pelleted by centrifugation and genomic DNA was extracted using a QIAmp DNA Mini Kit (Qiagen) according to the manufacturer’s instructions. Library preparation and short-read Illumina sequencing were performed by BMKGENE to confirm deletion of target genes and assess the degree of other polymorphisms in the genome. The resulting raw reads were cleaned by removing adaptor sequences, low-quality-end trimming and removal of low-quality reads using BBTools v 38.18 using the parameters trimq = 14, maq = 20, maxns = 0 and minlength = 45. (Bushnell, B. BBMap. Available from: <ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/bbmap/">https://sourceforge.net/projects/bbmap/</ext-link>.). The genetic changes in the strains as compared to the reference genome (GCF_000210855.2) were identified using breseq (v. 0.38) run in consensus mode with default parameters (<xref ref-type="bibr" rid="R58">58</xref>). Sequencing data is available from the European Nucleotide Archive (ENA) using the accession number PRJEB83585.</p></sec><sec id="S14"><title>Animal husbandry</title><p id="P32">Animal experiments were conducted in accordance with the Swiss Federal Government guidelines in animal experimentation law (SR 455.163 TVV). Protocols used were approved by the Cantonal Veterinary Office of the canton Zurich, Switzerland (Kantonales Veterinäramt ZH licenses 108/2022, 109/2022, 158/2019, 193/2016). Animals were bred and kept under specific pathogen free conditions in individually ventilated cages (EPIC and RCHCI facilities, ETH Zurich). Wild-type C57BL/6J mice were used for all <italic>in vivo</italic> experiments described here. Mice were aged 8-10 weeks at the start of experiments, and a balanced number of males and females was used. Mice were monitored daily and scored for health status in a range of criteria per animal licence requirements, and euthanised prior to experimental endpoint if necessary.</p></sec><sec id="S15"><title>Animal infection experiments</title><p id="P33">Mice were infected and treated following the experimental schemes described in each figure and corresponding figure legend. For infections requiring intraperitoneal injection, overnight cultures were incubated on a rotating wheel at 37 °C for 12 hours. Overnight cultures were washed in PBS then diluted to achieve approximately 10<sup>4</sup> CFU/ml. For single infections (<xref ref-type="fig" rid="F2">Fig 2B</xref>), mice received 100 μl of this washed solution by intraperitoneal injection giving an infectious dose of approximately 10<sup>3</sup> CFU. For mixed infections (<xref ref-type="fig" rid="F2">Fig 2D</xref>), mice received 100 μl of washed solution to achieve an inoculum of 10<sup>3</sup> CFU comprising equivalent volumes of each strain, as required. For infections requiring oral gavage (<xref ref-type="fig" rid="F3">Fig 3</xref>-<xref ref-type="fig" rid="F5">5</xref>), mice were gavaged with 25mg streptomycin one day prior to infection. Overnight cultures were used to inoculate subcultures which were incubated on a rotating wheel at 37 °C for 4 hours. Subcultures were washed in PBS then aliquoted to prepare inocula comprising approximately 5x10<sup>7</sup> CFU in a 50 μl volume, which was delivered to the mice by oral gavage. Faeces was collected in pre-weighed tubes containing 1 ml PBS and homogenised with a steel ball for 2 minutes at 25 Hz using a Tissue-Lyser (Qiagen). Mice were euthanised at indicated time-points, and organs were aseptically removed. CFU per organ was quantified by plating to MacConkey agar containing 50 ug / ml streptomycin. Data for liver, spleen, and mesenteric lymph node is presented as CFU per organ, while data for faeces is presented as CFU per gram of faeces.</p></sec><sec id="S16"><title>Measurement of genomic barcodes by qPCR</title><p id="P34">Overnight cultures were inoculated with homogenates of indicated organs to enrich for bacterial genetic material, comprising 100 μl homogenate in 2 ml LB and appropriate antibiotics. Cultures were incubated for 12 hours at 37 °C on a rotating wheel. Overnight cultures were pelleted by centrifugation and genomic DNA was extracted using a QIAmp DNA Mini Kit (Qiagen) according to the manufacturer’s instructions. The abundance of each genetic tag was measured by qPCR as described previously (<xref ref-type="bibr" rid="R59">59</xref>). Relative proportions of each tag were calculated by dividing the DNA copy number of each tag by the sum of all tags within a sample.</p></sec><sec id="S17"><title>Histology</title><p id="P35">Tissue samples were embedded in O.C.T. (Sakura), snap-frozen in liquid nitrogen, and stored at -80 °C. Cryosections were prepared at 5 μm width and mounted on glass slides, then stained with hematoxylin and eosin (H&amp;E). Pathological evaluation was performed in a blinded manner based on the criteria described previously (<xref ref-type="bibr" rid="R27">27</xref>). Briefly, samples were scored on four criteria: degree of submusocal edema; infiltration of polymorphonuclear granulocytes into the lamina propria; number of goblet cells; and integrity of the epithelia. Scores for each category were combined to achieve a total score representing the pathological state of each sample.</p></sec><sec id="S18"><title>Lipocalin-2 ELISA</title><p id="P36">Homogenised faecal samples were thawed from storage at -20 °C and centrifuged to remove faecal material. Lipocalin-2 levels in the supernatant were quantified using a Lipocalin-2 ELISA kit (R &amp; D Systems) according to the manufacturer’s instructions. All samples were analysed in duplicate at three different dilutions (undiluted, 1:20, and 1:400), and concentrations were determined by four parameter logistic regression curve.</p></sec><sec id="S19"><title>Gentamicin protection assay for cecal tissue</title><p id="P37">Cecal tissue was aseptically extracted from mice following euthanisation, and incubated for 30 minutes in PBS containing 400 μg/ml gentamicin to kill extracellular bacteria. Tissue was then washed rigorously six times in PBS, then homogenised with a steel ball for 2 minutes at 25 Hz using a Tissue-Lyser (Qiagen). CFU was quantified by plating to MacConkey agar containing 50 ug / ml streptomycin.</p></sec><sec id="S20"><title>Statistical analysis and software</title><p id="P38">GraphPad Prism was used to perform statistical tests and generate graphs. Where applicable, statistical significance was assessed by Mann-Whitney <italic>U</italic> test, as described in figure legends. BioRender was used to generate some graphical elements, including experimental schemes and <xref ref-type="fig" rid="F6">Fig 6</xref>. Figures were assembled in Abode Illustrator.</p></sec></sec><sec id="S21" sec-type="extended-data"><title>Extended Data</title><fig id="F7" position="anchor"><label>Extended data Figure 1</label><caption><p id="P39"><bold>A)</bold> Bacterial loads recovered from the mesenteric lymph node (left) and faeces (right) at day 4 post infection, (<italic>n</italic> = 5-7 mice per group). Data pertains to <xref ref-type="fig" rid="F2">Fig 2B</xref>. Dotted lines denote limit of detection. <bold>B)</bold> Bacterial loads recovered at day 2 post infection in the liver (upper left), spleen (upper right), mesenteric lymph node (bottom left), and faeces (bottom right). <bold>A-B)</bold> Statistical differences between WT and indicated groups determined by two-tailed Mann Whitney-U test, (p&gt;0.05 not significant (ns), p&lt;0.05 (*), p&lt;0.01 (**), p&lt;0.001 (***). <bold>C)</bold> Bacterial loads at indicated organs and in faeces at day 4 post infection. Data pertains to <xref ref-type="fig" rid="F2">Fig 2D</xref>. <bold>D)</bold> Relative proportion of tagged strains recovered from the liver (upper) and spleen (lower) of individual animals, as denoted on the X axis. Horizontal bars denote median. Data pertains to <xref ref-type="fig" rid="F2">Fig 2D</xref>.</p></caption><graphic xlink:href="EMS202049-f007"/></fig><fig id="F8" position="anchor"><label>Extended data Figure 2</label><caption><p id="P40"><bold>A-B)</bold> Bacterial populations in the gut determined by CFU plating of homogenised faecal samples to selective media. Dotted line at 102 CFU / g faeces denotes conservative limit of detection. <bold>A)</bold> Data pertains to <xref ref-type="fig" rid="F5">Fig. 5A</xref>, (<italic>n</italic> = 3-6 mice per group). <bold>B)</bold> Data pertains to <xref ref-type="fig" rid="F5">Fig 5B</xref>, (<italic>n</italic> = 5-7 mice per group).</p></caption><graphic xlink:href="EMS202049-f008"/></fig></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Material</label><media xlink:href="EMS202049-supplement-Supplementary_Material.pdf" mimetype="application" mime-subtype="pdf" id="d92aAcFbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgements</title><p>The authors would like to thank members of the Hardt lab for productive discussion and for technical support. We would like to thank the staff at RCHCI and EPIC animal facilities, and the staff at the Institute of Microbiology at ETH Zurich for their support.</p><sec id="S23"><title>Funding</title><p>This work has been funded by grants from the Swiss National Science Foundation</p><p>(310030B_173338/1, 310030_192567, 10.001.588) to WDH, and also supported by the NCCR Microbiomes, funded by the Swiss National Science Foundation (51NF40_180575; to SS and WDH). JPMN was supported by a Swiss Government Excellence Scholarship (2019.0843). NMA was funded by the National Institute of Health (AI083359) and The Welch Foundation (I-1704).</p></sec></ack><fn-group><fn id="FN4" fn-type="con"><p id="P41"><bold>Contributions</bold></p><p id="P42">J.P.M.N., F.G., P.P., A.M., S.M., and W.D.H. conceived and designed the experiments. J.P.M.N., F.G., P.P., A.M., A.S., M.B., Y.S., S.M., and U.E. performed the experiments. All authors contributed to data analysis and writing of the manuscript.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galan</surname><given-names>JE</given-names></name><name><surname>Waksman</surname><given-names>G</given-names></name></person-group>
<article-title>Protein-Injection Machines in Bacteria</article-title>
<source>Cell</source>
<year>2018</year>
<volume>172</volume>
<fpage>1306</fpage>
<lpage>1318</lpage>
<pub-id pub-id-type="pmcid">PMC5849082</pub-id><pub-id pub-id-type="pmid">29522749</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2018.01.034</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Marshall</surname><given-names>NC</given-names></name><name><surname>Rowland</surname><given-names>JL</given-names></name><name><surname>McCoy</surname><given-names>JM</given-names></name><name><surname>Worrall</surname><given-names>LJ</given-names></name><name><surname>Santos</surname><given-names>AS</given-names></name><name><surname>Strynadka</surname><given-names>NCJ</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group>
<article-title>Assembly, structure, function and regulation of type III secretion systems</article-title>
<source>Nat Rev Microbiol</source>
<year>2017</year>
<volume>15</volume>
<fpage>323</fpage>
<lpage>337</lpage>
<pub-id pub-id-type="pmid">28392566</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Aljahdali</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Harbottle</surname><given-names>H</given-names></name><name><surname>Hoffmann</surname><given-names>M</given-names></name><name><surname>Frye</surname><given-names>JG</given-names></name><name><surname>Foley</surname><given-names>SL</given-names></name></person-group>
<article-title>Infection biology of <italic>Salmonella enterica</italic></article-title>
<source>EcoSal Plus</source>
<volume>0</volume>
<elocation-id>eesp-0001-2023</elocation-id>
<pub-id pub-id-type="pmcid">PMC11636313</pub-id><pub-id pub-id-type="pmid">38415623</pub-id><pub-id pub-id-type="doi">10.1128/ecosalplus.esp-0001-2023</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galán</surname><given-names>JE</given-names></name><name><surname>Curtiss</surname><given-names>R</given-names><suffix>3rd</suffix></name></person-group>
<article-title>Cloning and molecular characterization of genes whose products allow Salmonella typhimurium to penetrate tissue culture cells</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>1989</year>
<volume>86</volume>
<fpage>6383</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmcid">PMC297844</pub-id><pub-id pub-id-type="pmid">2548211</pub-id><pub-id pub-id-type="doi">10.1073/pnas.86.16.6383</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galán</surname><given-names>JE</given-names></name></person-group>
<article-title>Salmonella Typhimurium and inflammation: a pathogen-centric affair</article-title>
<source>Nature Reviews Microbiology</source>
<year>2021</year>
<volume>19</volume>
<fpage>716</fpage>
<lpage>725</lpage>
<pub-id pub-id-type="pmcid">PMC9350856</pub-id><pub-id pub-id-type="pmid">34012042</pub-id><pub-id pub-id-type="doi">10.1038/s41579-021-00561-4</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fattinger</surname><given-names>SA</given-names></name><name><surname>Sellin</surname><given-names>ME</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name></person-group>
<article-title>Salmonella effector driven invasion of the gut epithelium: breaking in and setting the house on fire</article-title>
<source>Curr Opin Microbiol</source>
<year>2021</year>
<volume>64</volume>
<fpage>9</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="pmid">34492596</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shea</surname><given-names>JE</given-names></name><name><surname>Hensel</surname><given-names>M</given-names></name><name><surname>Gleeson</surname><given-names>C</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group>
<article-title>Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>1996</year>
<volume>93</volume>
<fpage>2593</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmcid">PMC39842</pub-id><pub-id pub-id-type="pmid">8637919</pub-id><pub-id pub-id-type="doi">10.1073/pnas.93.6.2593</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hensel</surname><given-names>M</given-names></name><name><surname>Shea</surname><given-names>JE</given-names></name><name><surname>Gleeson</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>MD</given-names></name><name><surname>Dalton</surname><given-names>E</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group>
<article-title>Simultaneous identification of bacterial virulence genes by negative selection</article-title>
<source>Science</source>
<year>1995</year>
<volume>269</volume>
<fpage>400</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmid">7618105</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maier</surname><given-names>L</given-names></name><name><surname>Diard</surname><given-names>M</given-names></name><name><surname>Sellin</surname><given-names>ME</given-names></name><name><surname>Chouffane</surname><given-names>ES</given-names></name><name><surname>Trautwein-Weidner</surname><given-names>K</given-names></name><name><surname>Periaswamy</surname><given-names>B</given-names></name><name><surname>Slack</surname><given-names>E</given-names></name><name><surname>Dolowschiak</surname><given-names>T</given-names></name><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Loverdo</surname><given-names>C</given-names></name><name><surname>Regoes</surname><given-names>RR</given-names></name><etal/></person-group>
<article-title>Granulocytes impose a tight bottleneck upon the gut luminal pathogen population during Salmonella typhimurium colitis</article-title>
<source>PLoS Pathog</source>
<year>2014</year>
<volume>10</volume>
<elocation-id>e1004557</elocation-id>
<pub-id pub-id-type="pmcid">PMC4270771</pub-id><pub-id pub-id-type="pmid">25522364</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004557</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hapfelmeier</surname><given-names>S</given-names></name><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Barthel</surname><given-names>M</given-names></name><name><surname>Kremer</surname><given-names>M</given-names></name><name><surname>Muller</surname><given-names>AJ</given-names></name><name><surname>Heikenwalder</surname><given-names>M</given-names></name><name><surname>Stallmach</surname><given-names>T</given-names></name><name><surname>Hensel</surname><given-names>M</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name></person-group>
<article-title>The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms</article-title>
<source>J Immunol</source>
<year>2005</year>
<volume>174</volume>
<fpage>1675</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="pmid">15661931</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>LaRock</surname><given-names>DL</given-names></name><name><surname>Chaudhary</surname><given-names>A</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name></person-group>
<article-title>Salmonellae interactions with host processes</article-title>
<source>Nat Rev Microbiol</source>
<year>2015</year>
<volume>13</volume>
<fpage>191</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="pmcid">PMC5074537</pub-id><pub-id pub-id-type="pmid">25749450</pub-id><pub-id pub-id-type="doi">10.1038/nrmicro3420</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pillay</surname><given-names>TD</given-names></name><name><surname>Hettiarachchi</surname><given-names>SU</given-names></name><name><surname>Gan</surname><given-names>J</given-names></name><name><surname>Diaz-Del-Olmo</surname><given-names>I</given-names></name><name><surname>Yu</surname><given-names>XJ</given-names></name><name><surname>Muench</surname><given-names>JH</given-names></name><name><surname>Thurston</surname><given-names>TLM</given-names></name><name><surname>Pearson</surname><given-names>JS</given-names></name></person-group>
<article-title>Speaking the host language: how Salmonella effector proteins manipulate the host</article-title>
<source>Microbiology (Reading)</source>
<year>2023</year>
<volume>169</volume>
<pub-id pub-id-type="pmcid">PMC10333799</pub-id><pub-id pub-id-type="pmid">37279149</pub-id><pub-id pub-id-type="doi">10.1099/mic.0.001342</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jennings</surname><given-names>E</given-names></name><name><surname>Thurston</surname><given-names>TLM</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group>
<article-title>Salmonella SPI-2 Type III Secretion System Effectors: Molecular Mechanisms And Physiological Consequences</article-title>
<source>Cell Host Microbe</source>
<year>2017</year>
<volume>22</volume>
<fpage>217</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="pmid">28799907</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haraga</surname><given-names>A</given-names></name><name><surname>Ohlson</surname><given-names>MB</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name></person-group>
<article-title>Salmonellae interplay with host cells</article-title>
<source>Nat Rev Microbiol</source>
<year>2008</year>
<volume>6</volume>
<fpage>53</fpage>
<lpage>66</lpage>
<pub-id pub-id-type="pmid">18026123</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Burford</surname><given-names>WB</given-names></name><name><surname>Pham</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Alto</surname><given-names>LT</given-names></name><name><surname>Ertelt</surname><given-names>JM</given-names></name><name><surname>Winter</surname><given-names>MG</given-names></name><name><surname>Winter</surname><given-names>SE</given-names></name><name><surname>Way</surname><given-names>SS</given-names></name><name><surname>Alto</surname><given-names>NM</given-names></name></person-group>
<article-title>Systematic reconstruction of an effector-gene network reveals determinants of Salmonella cellular and tissue tropism</article-title>
<source>Cell Host &amp; Microbe</source>
<year>2021</year>
<volume>29</volume>
<fpage>1531</fpage>
<lpage>1544</lpage>
<elocation-id>e9</elocation-id>
<pub-id pub-id-type="pmcid">PMC8516738</pub-id><pub-id pub-id-type="pmid">34536347</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2021.08.012</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bayer-Santos</surname><given-names>E</given-names></name><name><surname>Durkin</surname><given-names>CH</given-names></name><name><surname>Rigano</surname><given-names>LA</given-names></name><name><surname>Kupz</surname><given-names>A</given-names></name><name><surname>Alix</surname><given-names>E</given-names></name><name><surname>Cerny</surname><given-names>O</given-names></name><name><surname>Jennings</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>AS</given-names></name><name><surname>Lapaque</surname><given-names>N</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name><etal/></person-group>
<article-title>The Salmonella Effector SteD Mediates MARCH8-Dependent Ubiquitination of MHC II Molecules and Inhibits T Cell Activation</article-title>
<source>Cell Host &amp; Microbe</source>
<year>2016</year>
<volume>20</volume>
<fpage>584</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="pmcid">PMC5104694</pub-id><pub-id pub-id-type="pmid">27832589</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2016.10.007</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stapels</surname><given-names>DAC</given-names></name><name><surname>Hill</surname><given-names>PWS</given-names></name><name><surname>Westermann</surname><given-names>AJ</given-names></name><name><surname>Fisher</surname><given-names>RA</given-names></name><name><surname>Thurston</surname><given-names>TL</given-names></name><name><surname>Saliba</surname><given-names>AE</given-names></name><name><surname>Blommestein</surname><given-names>I</given-names></name><name><surname>Vogel</surname><given-names>J</given-names></name><name><surname>Helaine</surname><given-names>S</given-names></name></person-group>
<article-title>Salmonella persisters undermine host immune defenses during antibiotic treatment</article-title>
<source>Science</source>
<year>2018</year>
<volume>362</volume>
<fpage>1156</fpage>
<lpage>1160</lpage>
<pub-id pub-id-type="pmid">30523110</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buckner</surname><given-names>MMC</given-names></name><name><surname>Croxen</surname><given-names>M</given-names></name><name><surname>Arena</surname><given-names>ET</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group>
<article-title>A comprehensive study of the contribution of Salmonella enterica serovar Typhimurium SPI2 effectors to bacterial colonization, survival, and replication in typhoid fever, macrophage, and epithelial cell infection models</article-title>
<source>Virulence</source>
<year>2011</year>
<volume>2</volume>
<fpage>208</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="pmcid">PMC3149682</pub-id><pub-id pub-id-type="pmid">21540636</pub-id><pub-id pub-id-type="doi">10.4161/viru.2.3.15894</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knuff-Janzen</surname><given-names>K</given-names></name><name><surname>Tupin</surname><given-names>A</given-names></name><name><surname>Yurist-Doutsch</surname><given-names>S</given-names></name><name><surname>Rowland</surname><given-names>JL</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group>
<article-title>Multiple Salmonella-pathogenicity island 2 effectors are required to facilitate bacterial establishment of its intracellular niche and virulence</article-title>
<source>PLOS ONE</source>
<year>2020</year>
<volume>15</volume>
<elocation-id>e0235020</elocation-id>
<pub-id pub-id-type="pmcid">PMC7316343</pub-id><pub-id pub-id-type="pmid">32584855</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0235020</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsuda</surname><given-names>S</given-names></name><name><surname>Haneda</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Okada</surname><given-names>N</given-names></name></person-group>
<article-title>Salmonella enterica Effectors SifA, SpvB, SseF, SseJ, and SteA Contribute to Type III Secretion System 1 -Independent Inflammation in a Streptomycin-Pretreated Mouse Model of Colitis</article-title>
<source>Infect Immun</source>
<year>2019</year>
<volume>87</volume>
<pub-id pub-id-type="pmcid">PMC6704597</pub-id><pub-id pub-id-type="pmid">31235639</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00872-18</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shea</surname><given-names>JE</given-names></name><name><surname>Beuzon</surname><given-names>CR</given-names></name><name><surname>Gleeson</surname><given-names>C</given-names></name><name><surname>Mundy</surname><given-names>R</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group>
<article-title>Influence of the Salmonella typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the mouse</article-title>
<source>Infect Immun</source>
<year>1999</year>
<volume>67</volume>
<fpage>213</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmcid">PMC96299</pub-id><pub-id pub-id-type="pmid">9864218</pub-id><pub-id pub-id-type="doi">10.1128/iai.67.1.213-219.1999</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lawley</surname><given-names>TD</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Thompson</surname><given-names>LJ</given-names></name><name><surname>Kim</surname><given-names>CC</given-names></name><name><surname>Govoni</surname><given-names>GR</given-names></name><name><surname>Monack</surname><given-names>DM</given-names></name></person-group>
<article-title>Genome-wide screen for Salmonella genes required for long-term systemic infection of the mouse</article-title>
<source>PLoS Pathog</source>
<year>2006</year>
<volume>2</volume>
<fpage>e11</fpage>
<pub-id pub-id-type="pmcid">PMC1383486</pub-id><pub-id pub-id-type="pmid">16518469</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.0020011</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Daniel</surname><given-names>BBJ</given-names></name><name><surname>Steiger</surname><given-names>Y</given-names></name><name><surname>Sintsova</surname><given-names>A</given-names></name><name><surname>Field</surname><given-names>CM</given-names></name><name><surname>Nguyen</surname><given-names>BD</given-names></name><name><surname>Schubert</surname><given-names>C</given-names></name><name><surname>Cherrak</surname><given-names>Y</given-names></name><name><surname>Sunagawa</surname><given-names>S</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name><name><surname>Vorholt</surname><given-names>JA</given-names></name></person-group>
<article-title>Assessing microbiome population dynamics using wild-type isogenic standardized hybrid (WISH)-tags</article-title>
<source>Nat Microbiol</source>
<year>2024</year>
<volume>9</volume>
<fpage>1103</fpage>
<lpage>1116</lpage>
<pub-id pub-id-type="pmcid">PMC10994841</pub-id><pub-id pub-id-type="pmid">38503975</pub-id><pub-id pub-id-type="doi">10.1038/s41564-024-01634-9</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sintsova</surname><given-names>A</given-names></name><name><surname>Ruscheweyh</surname><given-names>HJ</given-names></name><name><surname>Field</surname><given-names>CM</given-names></name><name><surname>Feer</surname><given-names>L</given-names></name><name><surname>Nguyen</surname><given-names>BD</given-names></name><name><surname>Daniel</surname><given-names>B</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name><name><surname>Vorholt</surname><given-names>JA</given-names></name><name><surname>Sunagawa</surname><given-names>S</given-names></name></person-group>
<article-title>mBARq: a versatile and user-friendly framework for the analysis of DNA barcodes from transposon insertion libraries, knockout mutants, and isogenic strain populations</article-title>
<source>Bioinformatics</source>
<year>2024</year>
<volume>40</volume>
<pub-id pub-id-type="pmcid">PMC10885212</pub-id><pub-id pub-id-type="pmid">38341646</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btae078</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>AT</given-names></name><name><surname>McSorley</surname><given-names>SJ</given-names></name></person-group>
<article-title>Fighting the enemy within: Systemic immune defense against mucosal Salmonella infection</article-title>
<source>Immunol Lett</source>
<year>2024</year>
<volume>270</volume>
<elocation-id>106930</elocation-id>
<pub-id pub-id-type="pmid">39343314</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coburn</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Owen</surname><given-names>D</given-names></name><name><surname>Vallance</surname><given-names>BA</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group>
<article-title>Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis</article-title>
<source>Infect Immun</source>
<year>2005</year>
<volume>73</volume>
<fpage>3219</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmcid">PMC1111876</pub-id><pub-id pub-id-type="pmid">15908346</pub-id><pub-id pub-id-type="doi">10.1128/IAI.73.6.3219-3227.2005</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barthel</surname><given-names>M</given-names></name><name><surname>Hapfelmeier</surname><given-names>S</given-names></name><name><surname>Quintanilla-Martinez</surname><given-names>L</given-names></name><name><surname>Kremer</surname><given-names>M</given-names></name><name><surname>Rohde</surname><given-names>M</given-names></name><name><surname>Hogardt</surname><given-names>M</given-names></name><name><surname>Pfeffer</surname><given-names>K</given-names></name><name><surname>Russmann</surname><given-names>H</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name></person-group>
<article-title>Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host</article-title>
<source>Infect Immun</source>
<year>2003</year>
<volume>71</volume>
<fpage>2839</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmcid">PMC153285</pub-id><pub-id pub-id-type="pmid">12704158</pub-id><pub-id pub-id-type="doi">10.1128/IAI.71.5.2839-2858.2003</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaniga</surname><given-names>K</given-names></name><name><surname>Bossio</surname><given-names>JC</given-names></name><name><surname>Galán</surname><given-names>JE</given-names></name></person-group>
<article-title>The Salmonella typhimurium invasion genes invF and invG encode homologues of the AraC and PulD family of proteins</article-title>
<source>Mol Microbiol</source>
<year>1994</year>
<volume>13</volume>
<fpage>555</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="pmid">7997169</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Robbiani</surname><given-names>R</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><name><surname>Westendorf</surname><given-names>AM</given-names></name><name><surname>Barthel</surname><given-names>M</given-names></name><name><surname>Kremer</surname><given-names>M</given-names></name><name><surname>Chaffron</surname><given-names>S</given-names></name><name><surname>Macpherson</surname><given-names>AJ</given-names></name><name><surname>Buer</surname><given-names>J</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Dougan</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota</article-title>
<source>PLoS Biol</source>
<year>2007</year>
<volume>5</volume>
<fpage>2177</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="pmcid">PMC1951780</pub-id><pub-id pub-id-type="pmid">17760501</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0050244</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diard</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>V</given-names></name><name><surname>Maier</surname><given-names>L</given-names></name><name><surname>Remus-Emsermann</surname><given-names>MN</given-names></name><name><surname>Regoes</surname><given-names>RR</given-names></name><name><surname>Ackermann</surname><given-names>M</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name></person-group>
<article-title>Stabilization of cooperative virulence by the expression of an avirulent phenotype</article-title>
<source>Nature</source>
<year>2013</year>
<volume>494</volume>
<fpage>353</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">23426324</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gül</surname><given-names>E</given-names></name><name><surname>Bakkeren</surname><given-names>E</given-names></name><name><surname>Salazar</surname><given-names>G</given-names></name><name><surname>Steiger</surname><given-names>Y</given-names></name><name><surname>Abi Younes</surname><given-names>A</given-names></name><name><surname>Clerc</surname><given-names>M</given-names></name><name><surname>Christen</surname><given-names>P</given-names></name><name><surname>Fattinger</surname><given-names>SA</given-names></name><name><surname>Nguyen</surname><given-names>BD</given-names></name><name><surname>Kiefer</surname><given-names>P</given-names></name><name><surname>Slack</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The microbiota conditions a gut milieu that selects for wild-type Salmonella Typhimurium virulence</article-title>
<source>PLoS Biol</source>
<year>2023</year>
<volume>21</volume>
<elocation-id>e3002253</elocation-id>
<pub-id pub-id-type="pmcid">PMC10499267</pub-id><pub-id pub-id-type="pmid">37651408</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3002253</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spanò</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Hannemann</surname><given-names>S</given-names></name><name><surname>Lara-Tejero</surname><given-names>M</given-names></name><name><surname>Galán</surname><given-names>JE</given-names></name></person-group>
<article-title>A Bacterial Pathogen Targets a Host Rab-Family GTPase Defense Pathway with a GAP</article-title>
<source>Cell Host Microbe</source>
<year>2016</year>
<volume>19</volume>
<fpage>216</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmcid">PMC4854434</pub-id><pub-id pub-id-type="pmid">26867180</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2016.01.004</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dolowschiak</surname><given-names>T</given-names></name><name><surname>Mueller</surname><given-names>AA</given-names></name><name><surname>Pisan</surname><given-names>LJ</given-names></name><name><surname>Feigelman</surname><given-names>R</given-names></name><name><surname>Felmy</surname><given-names>B</given-names></name><name><surname>Sellin</surname><given-names>ME</given-names></name><name><surname>Namineni</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>BD</given-names></name><name><surname>Wotzka</surname><given-names>SY</given-names></name><name><surname>Heikenwalder</surname><given-names>M</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>IFN-gamma Hinders Recovery from Mucosal Inflammation during Antibiotic Therapy for Salmonella Gut Infection</article-title>
<source>Cell Host Microbe</source>
<year>2016</year>
<volume>20</volume>
<fpage>238</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="pmid">27453483</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fattinger</surname><given-names>SA</given-names></name><name><surname>Bock</surname><given-names>D</given-names></name><name><surname>Di Martino</surname><given-names>ML</given-names></name><name><surname>Deuring</surname><given-names>S</given-names></name><name><surname>Samperio Ventayol</surname><given-names>P</given-names></name><name><surname>Ek</surname><given-names>V</given-names></name><name><surname>Furter</surname><given-names>M</given-names></name><name><surname>Kreibich</surname><given-names>S</given-names></name><name><surname>Bosia</surname><given-names>F</given-names></name><name><surname>Muller-Hauser</surname><given-names>AA</given-names></name><name><surname>Nguyen</surname><given-names>BD</given-names></name><etal/></person-group>
<article-title>Salmonella Typhimurium discreet-invasion of the murine gut absorptive epithelium</article-title>
<source>PLoS Pathog</source>
<year>2020</year>
<volume>16</volume>
<elocation-id>e1008503</elocation-id>
<pub-id pub-id-type="pmcid">PMC7224572</pub-id><pub-id pub-id-type="pmid">32365138</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008503</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruano-Gallego</surname><given-names>D</given-names></name><name><surname>Sanchez-Garrido</surname><given-names>J</given-names></name><name><surname>Kozik</surname><given-names>Z</given-names></name><name><surname>Nunez-Berrueco</surname><given-names>E</given-names></name><name><surname>Cepeda-Molero</surname><given-names>M</given-names></name><name><surname>Mullineaux-Sanders</surname><given-names>C</given-names></name><name><surname>Naemi-Baghshomali Clark</surname><given-names>J</given-names></name><name><surname>Slater</surname><given-names>SL</given-names></name><name><surname>Wagner</surname><given-names>N</given-names></name><name><surname>Glegola-Madejska</surname><given-names>I</given-names></name><name><surname>Roumeliotis</surname><given-names>TI</given-names></name><etal/></person-group>
<article-title>Type III secretion system effectors form robust and flexible intracellular virulence networks</article-title>
<source>Science</source>
<year>2021</year>
<volume>371</volume>
<pub-id pub-id-type="pmid">33707240</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanchez-Garrido</surname><given-names>J</given-names></name><name><surname>Alberdi</surname><given-names>L</given-names></name><name><surname>Chatterjee</surname><given-names>S</given-names></name><name><surname>Frankel</surname><given-names>G</given-names></name><name><surname>Mullineaux-Sanders</surname><given-names>C</given-names></name></person-group>
<article-title>Type III secretion system effector subnetworks elicit distinct host immune responses to infection</article-title>
<source>Curr Opin Microbiol</source>
<year>2021</year>
<volume>64</volume>
<fpage>19</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmid">34537517</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanchez-Garrido</surname><given-names>J</given-names></name><name><surname>Ruano-Gallego</surname><given-names>D</given-names></name><name><surname>Choudhary</surname><given-names>JS</given-names></name><name><surname>Frankel</surname><given-names>G</given-names></name></person-group>
<article-title>The type III secretion system effector network hypothesis</article-title>
<source>Trends Microbiol</source>
<year>2022</year>
<volume>30</volume>
<fpage>524</fpage>
<lpage>533</lpage>
<pub-id pub-id-type="pmid">34840074</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spanò</surname><given-names>S</given-names></name><name><surname>Galán</surname><given-names>JE</given-names></name></person-group>
<article-title>A Rab32-dependent pathway contributes to Salmonella typhi host restriction</article-title>
<source>Science</source>
<year>2012</year>
<volume>338</volume>
<fpage>960</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="pmcid">PMC3693731</pub-id><pub-id pub-id-type="pmid">23162001</pub-id><pub-id pub-id-type="doi">10.1126/science.1229224</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerondopoulos</surname><given-names>A</given-names></name><name><surname>Langemeyer</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>J-R</given-names></name><name><surname>Linford</surname><given-names>A</given-names></name><name><surname>Barr Francis</surname><given-names>A</given-names></name></person-group>
<article-title>BLOC-3 Mutated in Hermansky-Pudlak Syndrome Is a Rab32/38 Guanine Nucleotide Exchange Factor</article-title>
<source>Current Biology</source>
<year>2012</year>
<volume>22</volume>
<fpage>2135</fpage>
<lpage>2139</lpage>
<pub-id pub-id-type="pmcid">PMC3502862</pub-id><pub-id pub-id-type="pmid">23084991</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2012.09.020</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Boot</surname><given-names>M</given-names></name><name><surname>Shao</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>SJ</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Lam</surname><given-names>TT</given-names></name><name><surname>Lara-Tejero</surname><given-names>M</given-names></name><name><surname>Rego</surname><given-names>EH</given-names></name><name><surname>Galán</surname><given-names>JE</given-names></name></person-group>
<article-title>Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella</article-title>
<source>Science</source>
<year>2020</year>
<volume>369</volume>
<fpage>450</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="pmcid">PMC8020367</pub-id><pub-id pub-id-type="pmid">32703879</pub-id><pub-id pub-id-type="doi">10.1126/science.aaz1333</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lian</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Schueder</surname><given-names>F</given-names></name><name><surname>Lara-Tejero</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Galán</surname><given-names>JE</given-names></name></person-group>
<article-title>Parkinson’s disease kinase LRRK2 coordinates a cell-intrinsic itaconate-dependent defence pathway against intracellular Salmonella</article-title>
<source>Nat Microbiol</source>
<year>2023</year>
<volume>8</volume>
<fpage>1880</fpage>
<lpage>1895</lpage>
<pub-id pub-id-type="pmcid">PMC10962312</pub-id><pub-id pub-id-type="pmid">37640963</pub-id><pub-id pub-id-type="doi">10.1038/s41564-023-01459-y</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Michelucci</surname><given-names>A</given-names></name><name><surname>Cordes</surname><given-names>T</given-names></name><name><surname>Ghelfi</surname><given-names>J</given-names></name><name><surname>Pailot</surname><given-names>A</given-names></name><name><surname>Reiling</surname><given-names>N</given-names></name><name><surname>Goldmann</surname><given-names>O</given-names></name><name><surname>Binz</surname><given-names>T</given-names></name><name><surname>Wegner</surname><given-names>A</given-names></name><name><surname>Tallam</surname><given-names>A</given-names></name><name><surname>Rausell</surname><given-names>A</given-names></name><name><surname>Buttini</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2013</year>
<volume>110</volume>
<fpage>7820</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmcid">PMC3651434</pub-id><pub-id pub-id-type="pmid">23610393</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1218599110</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hiyoshi</surname><given-names>H</given-names></name><name><surname>English</surname><given-names>BC</given-names></name><name><surname>Diaz-Ochoa</surname><given-names>VE</given-names></name><name><surname>Wangdi</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>LF</given-names></name><name><surname>Sakaguchi</surname><given-names>M</given-names></name><name><surname>Haneda</surname><given-names>T</given-names></name><name><surname>Tsolis</surname><given-names>RM</given-names></name><name><surname>Bäumler</surname><given-names>AJ</given-names></name></person-group>
<article-title>Virulence factors perforate the pathogen-containing vacuole to signal efferocytosis</article-title>
<source>Cell Host Microbe</source>
<year>2022</year>
<volume>30</volume>
<fpage>163</fpage>
<lpage>170</lpage>
<elocation-id>e6</elocation-id>
<pub-id pub-id-type="pmcid">PMC8831471</pub-id><pub-id pub-id-type="pmid">34951948</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2021.12.001</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knodler</surname><given-names>LA</given-names></name><name><surname>Vallance</surname><given-names>BA</given-names></name><name><surname>Celli</surname><given-names>J</given-names></name><name><surname>Winfree</surname><given-names>S</given-names></name><name><surname>Hansen</surname><given-names>B</given-names></name><name><surname>Montero</surname><given-names>M</given-names></name><name><surname>Steele-Mortimer</surname><given-names>O</given-names></name></person-group>
<article-title>Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2010</year>
<volume>107</volume>
<fpage>17733</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmcid">PMC2955089</pub-id><pub-id pub-id-type="pmid">20876119</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1006098107</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grant</surname><given-names>AJ</given-names></name><name><surname>Morgan</surname><given-names>FJ</given-names></name><name><surname>McKinley</surname><given-names>TJ</given-names></name><name><surname>Foster</surname><given-names>GL</given-names></name><name><surname>Maskell</surname><given-names>DJ</given-names></name><name><surname>Mastroeni</surname><given-names>P</given-names></name></person-group>
<article-title>Attenuated Salmonella Typhimurium lacking the pathogenicity island-2 type 3 secretion system grow to high bacterial numbers inside phagocytes in mice</article-title>
<source>PLoS Pathog</source>
<year>2012</year>
<volume>8</volume>
<elocation-id>e1003070</elocation-id>
<pub-id pub-id-type="pmcid">PMC3516571</pub-id><pub-id pub-id-type="pmid">23236281</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003070</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roudier</surname><given-names>C</given-names></name><name><surname>Fierer</surname><given-names>J</given-names></name><name><surname>Guiney</surname><given-names>DG</given-names></name></person-group>
<article-title>Characterization of translation termination mutations in the spv operon of the Salmonella virulence plasmid pSDL2</article-title>
<source>Journal of Bacteriology</source>
<year>1992</year>
<volume>174</volume>
<fpage>6418</fpage>
<lpage>6423</lpage>
<pub-id pub-id-type="pmcid">PMC207594</pub-id><pub-id pub-id-type="pmid">1400193</pub-id><pub-id pub-id-type="doi">10.1128/jb.174.20.6418-6423.1992</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guiney</surname><given-names>DG</given-names></name><name><surname>Fierer</surname><given-names>J</given-names></name></person-group>
<article-title>The Role of the spv Genes in Salmonella Pathogenesis</article-title>
<source>Frontiers in Microbiology</source>
<year>2011</year>
<volume>2</volume>
<pub-id pub-id-type="pmcid">PMC3117207</pub-id><pub-id pub-id-type="pmid">21716657</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2011.00129</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lesnick</surname><given-names>ML</given-names></name><name><surname>Reiner</surname><given-names>NE</given-names></name><name><surname>Fierer</surname><given-names>J</given-names></name><name><surname>Guiney</surname><given-names>DG</given-names></name></person-group>
<article-title>The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells</article-title>
<source>Mol Microbiol</source>
<year>2001</year>
<volume>39</volume>
<fpage>1464</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">11260464</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tezcan-Merdol</surname><given-names>D</given-names></name><name><surname>Nyman</surname><given-names>T</given-names></name><name><surname>Lindberg</surname><given-names>U</given-names></name><name><surname>Haag</surname><given-names>F</given-names></name><name><surname>Koch-Nolte</surname><given-names>F</given-names></name><name><surname>Rhen</surname><given-names>M</given-names></name></person-group>
<article-title>Actin is ADP-ribosylated by the Salmonella enterica virulence-associated protein SpvB</article-title>
<source>Mol Microbiol</source>
<year>2001</year>
<volume>39</volume>
<fpage>606</fpage>
<lpage>19</lpage>
<pub-id pub-id-type="pmid">11169102</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Libby</surname><given-names>SJ</given-names></name><name><surname>Lesnick</surname><given-names>M</given-names></name><name><surname>Hasegawa</surname><given-names>P</given-names></name><name><surname>Weidenhammer</surname><given-names>E</given-names></name><name><surname>Guiney</surname><given-names>DG</given-names></name></person-group>
<article-title>The Salmonella virulence plasmid spv genes are required for cytopathology in human monocyte-derived macrophages</article-title>
<source>Cell Microbiol</source>
<year>2000</year>
<volume>2</volume>
<fpage>49</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="pmid">11207562</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mazurkiewicz</surname><given-names>P</given-names></name><name><surname>Thomas</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Arbibe</surname><given-names>L</given-names></name><name><surname>Sansonetti</surname><given-names>P</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group>
<article-title>SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases</article-title>
<source>Mol Microbiol</source>
<year>2008</year>
<volume>67</volume>
<fpage>1371</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmcid">PMC2268955</pub-id><pub-id pub-id-type="pmid">18284579</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06134.x</pub-id></mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haneda</surname><given-names>T</given-names></name><name><surname>Ishii</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Ohshima</surname><given-names>K</given-names></name><name><surname>lida</surname><given-names>N</given-names></name><name><surname>Danbara</surname><given-names>H</given-names></name><name><surname>Okada</surname><given-names>N</given-names></name></person-group>
<article-title>Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection</article-title>
<source>Cell Microbiol</source>
<year>2012</year>
<volume>14</volume>
<fpage>485</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="pmid">22188134</pub-id></mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Long</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>D-C</given-names></name><name><surname>Shao</surname><given-names>F</given-names></name></person-group>
<article-title>Structural Insights into the Enzymatic Mechanism of the Pathogenic MAPK Phosphothreonine Lyase</article-title>
<source>Molecular Cell</source>
<year>2007</year>
<volume>28</volume>
<fpage>899</fpage>
<lpage>913</lpage>
<pub-id pub-id-type="pmid">18060821</pub-id></mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grabe</surname><given-names>GJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Przydacz</surname><given-names>M</given-names></name><name><surname>Rolhion</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Pruneda</surname><given-names>JN</given-names></name><name><surname>Komander</surname><given-names>D</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name><name><surname>Hare</surname><given-names>SA</given-names></name></person-group>
<article-title>The Salmonella Effector SpvD Is a Cysteine Hydrolase with a Serovar-specific Polymorphism Influencing Catalytic Activity, Suppression of Immune Responses, and Bacterial Virulence</article-title>
<source>J Biol Chem</source>
<year>2016</year>
<volume>291</volume>
<fpage>25853</fpage>
<lpage>25863</lpage>
<pub-id pub-id-type="pmcid">PMC5207060</pub-id><pub-id pub-id-type="pmid">27789710</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M116.752782</pub-id></mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rolhion</surname><given-names>N</given-names></name><name><surname>Furniss</surname><given-names>RCD</given-names></name><name><surname>Grabe</surname><given-names>G</given-names></name><name><surname>Ryan</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Matthews</surname><given-names>SA</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group>
<article-title>Inhibition of Nuclear Transport of <bold>NF-<sc>k</sc>B</bold> p65 by the Salmonella Type III Secretion System Effector SpvD</article-title>
<source>PLOS Pathogens</source>
<year>2016</year>
<volume>12</volume>
<elocation-id>e1005653</elocation-id>
<pub-id pub-id-type="pmcid">PMC4883751</pub-id><pub-id pub-id-type="pmid">27232334</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005653</pub-id></mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoiseth</surname><given-names>SK</given-names></name><name><surname>Stocker</surname><given-names>BA</given-names></name></person-group>
<article-title>Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines</article-title>
<source>Nature</source>
<year>1981</year>
<volume>291</volume>
<fpage>238</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">7015147</pub-id></mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group>
<article-title>One-step inactivation of chromosomal genes in <italic>Escherichia coli</italic> K-12 using PCR products</article-title>
<source>Proceedings of the National Academy of Sciences</source>
<year>2000</year>
<volume>97</volume>
<fpage>6640</fpage>
<lpage>6645</lpage>
<pub-id pub-id-type="pmcid">PMC18686</pub-id><pub-id pub-id-type="pmid">10829079</pub-id><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id></mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deatherage</surname><given-names>DE</given-names></name><name><surname>Barrick</surname><given-names>JE</given-names></name></person-group>
<article-title>Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq</article-title>
<source>Methods Mol Biol</source>
<year>2014</year>
<volume>1151</volume>
<fpage>165</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmcid">PMC4239701</pub-id><pub-id pub-id-type="pmid">24838886</pub-id><pub-id pub-id-type="doi">10.1007/978-1-4939-0554-6_12</pub-id></mixed-citation></ref><ref id="R59"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grant</surname><given-names>AJ</given-names></name><name><surname>Restif</surname><given-names>O</given-names></name><name><surname>McKinley</surname><given-names>TJ</given-names></name><name><surname>Sheppard</surname><given-names>M</given-names></name><name><surname>Maskell</surname><given-names>DJ</given-names></name><name><surname>Mastroeni</surname><given-names>P</given-names></name></person-group>
<article-title>Modelling within-host spatiotemporal dynamics of invasive bacterial disease</article-title>
<source>PLoS Biol</source>
<year>2008</year>
<volume>6</volume>
<fpage>e74</fpage>
<pub-id pub-id-type="pmcid">PMC2288627</pub-id><pub-id pub-id-type="pmid">18399718</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0060074</pub-id></mixed-citation></ref><ref id="R60"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Periaswamy</surname><given-names>B</given-names></name><name><surname>Maier</surname><given-names>L</given-names></name><name><surname>Vishwakarma</surname><given-names>V</given-names></name><name><surname>Slack</surname><given-names>E</given-names></name><name><surname>Kremer</surname><given-names>M</given-names></name><name><surname>Andrews-Polymenis</surname><given-names>HL</given-names></name><name><surname>McClelland</surname><given-names>M</given-names></name><name><surname>Grant</surname><given-names>AJ</given-names></name><name><surname>Suar</surname><given-names>M</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name></person-group>
<article-title>Live attenuated S. Typhimurium vaccine with improved safety in immuno-compromised mice</article-title>
<source>PLoS One</source>
<year>2012</year>
<volume>7</volume>
<elocation-id>e45433</elocation-id>
<pub-id pub-id-type="pmcid">PMC3454430</pub-id><pub-id pub-id-type="pmid">23029007</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0045433</pub-id></mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schubert</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>BD</given-names></name><name><surname>Sichert</surname><given-names>A</given-names></name><name><surname>Näpflin</surname><given-names>N</given-names></name><name><surname>Sintsova</surname><given-names>A</given-names></name><name><surname>Feer</surname><given-names>L</given-names></name><name><surname>Näf</surname><given-names>J</given-names></name><name><surname>Daniel</surname><given-names>BBJ</given-names></name><name><surname>Steiger</surname><given-names>Y</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name><name><surname>Sauer</surname><given-names>U</given-names></name><etal/></person-group>
<article-title>Monosaccharides Drive <italic>Salmonella</italic> Gut Colonization in a Context-Dependent Manner</article-title>
<source>bioRxiv</source>
<year>2024</year>
<pub-id pub-id-type="doi">10.1101/2024.08.06.606610:2024.08.06.606610</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Functional grouping of SPI-2 effector genes permits rationally designed multimutants</title><p><bold>A)</bold> Graphic representation of reported functions for SPI-2 T3SS effector proteins. Effectors are loosely grouped into five different functional groups based on literature. Some effectors reportedly contribute to different functional groups and are represented twice here. <bold>B)</bold> Schematic representation of workflow to generate complex multimutants. Single mutants were created by lambda red recombination to replace genes of interest with cassettes encoding either kanamycin (::<italic>aphT)</italic> or chloramphenicol (::<italic>cat</italic>) resistance, followed by generation of P22 lysates containing phage that have packaged these deletions. Successive rounds of sequential P22 transduction and Flp-FRT removal of resistance cassettes resulted in mutants deficient for three to six effector genes, as required. Mutant strains were validated by whole genome sequencing to confirm deletion of target genes and to assess the degree of other changes to the genome. <bold>C)</bold> Rational design of SPI-2 effector multimutant strains based on reported functions described in Fig 1A. Six multimutant strains were constructed in duplicate and assigned designations based on the Greek alphabet (left) by deletion of effector genes in the sequence shown (right) to produce distinct multimutant genotypes (middle). <bold>D)</bold> Bioinformatic analysis confirming the deletion of target genes from corresponding multimutant strains. Blue rectangles correspond to absence of reads mapping to chromosomal regions encoding these genes. Two independently-constructed multimutant strains were analysed. Gene position (top) corresponds to position on the chromosome of S.Typhimurium SL1344, while other regions of the chromosome are not shown.</p></caption><graphic xlink:href="EMS202049-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Systemic infection is compromised by deletion of SPI-2 effector cohorts</title><p><bold>A)</bold> Experimental scheme to study virulence of S.Tm mutants during systemic infection <italic>in vivo</italic>. Mice were infected with 10<sup>3</sup> <italic>S</italic>.Tm by intraperitoneal injection. Mice were euthanised at day 4 post infection, and bacterial loads in the spleen and liver were quantified by CFU plating to selective media. <bold>B)</bold> S.Tm recovered from the liver (left) and spleen (right), (<italic>n</italic> = 5-7 mice per group). Horizontal bars denote median. Statistical differences between WT and indicated groups determined by two-tailed Mann Whitney-U test, (p&gt;0.05 not significant (ns), p&lt;0.05 (*), p&lt;0.01 (**), p&lt;0.001 (***). <bold>C)</bold> Experimental scheme to study relative fitness of S.Tm mutants <italic>in vivo</italic> by competitive infection. Mice were infected with a mixed inoculum comprising equal volumes of 9 different <italic>S</italic>.Tm strains each bearing unique chromosomal tags. Mice were euthanised at day 4 post infection. <bold>D)</bold> Relative proportion of each genetic tag determined by RT-qPCR. Data is presented as the proportion of a given tag relative to the other tags within one animal. Coloured circles represent tagged strain recovered from the liver (left) and spleen (right) of infected mice. Horizontal bars denote median.</p></caption><graphic xlink:href="EMS202049-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>SPI-2 effectors support bacterial migration to systemic niches</title><p><bold>A) )</bold> Experimental scheme to study virulence of S.Tm mutants during oral infection <italic>in vivo</italic>. Mice were pre-treated with streptomycin by oral gavage, then received an infectious dose of 5x10^7 S.Tm by oral gavage. Faeces were collected at indicated time points and mice were euthanised at day 4 post infection. <bold>B-C)</bold> Bacterial loads recovered from <bold>B)</bold> the liver (left), spleen (right) and <bold>C)</bold> mesenteric lymph node at day 4 post infection (<italic>n</italic> = 5 mice per group). Dotted lines denote limit of detection. Horizontal bars denote median. <bold>D)</bold> Bacterial populations in the gut determined by CFU plating of homogenised faecal samples to selective media. Dotted line at 10<sup>2</sup> CFU / g faeces denotes conservative limit of detection (<italic>n</italic> = 5 mice per group). Horizontal bars denote median. <bold>E-F)</bold> Caecal histology at day 4 post infection. <bold>E)</bold> combined pathology score based on scoring criteria quantifying submucosal edema, epithelial barrier integrity, goblet cell number, and infiltration of polymorphonuclear granulocytes. <bold>F)</bold> representative micrographs of cecum samples stained with hematoxylin and eosin. Lu. lumen, S.E. submucosal edema. <bold>B-C, E)</bold> Statistical differences between WT and indicated groups determined by two-tailed Mann Whitney-U test, (p&gt;0.05 not significant (ns), p&lt;0.05 (*), p&lt;0.01 (**), p&lt;0.001 (***).</p></caption><graphic xlink:href="EMS202049-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Effector cohorts contribute to SPI-2 T3SS-dependent inflammation.</title><p><bold>A)</bold> Bacterial loads recovered from the liver (left), spleen (middle), and mesenteric lymph node (right) at day 4 post infection (<italic>n</italic> = 5 mice per group). Mice were infected as in <xref ref-type="fig" rid="F3">Fig. 3A</xref>. Dotted lines denote limit of detection. Horizontal bars denote median. <bold>B)</bold> Bacterial populations in the gut determined by CFU plating of homogenised faecal samples to selective media. Dotted line at 102CFU / g faeces denotes conservative limit of detection (<italic>n</italic> = 5 mice per group). Horizontal bars denote median. <bold>C)</bold> Levels of gut inflammation at indicated days post infection determined by ELISA quantification of lipocalin-2 (LCN2). Horizonal dotted line (upper) represents typical threshold of moderately inflamed gut, while dotted line (lower) represents limit of detection. Horizontal bars denote median. <bold>D-E</bold>) Caecal histology at day 4 post infection. <bold>D)</bold> combined pathology score based on scoring criteria quantifying submucosal edema, epithelial barrier integrity, goblet cell number, and infiltration of polymorphonuclear granulocytes. <bold>E)</bold> representative micrographs of cecum samples stained with hematoxylin and eosin. Lu. lumen, S.E. submucosal edema. <bold>A, C-E)</bold> Statistical differences between WT and indicated groups determined by two-tailed Mann Whitney-U test, (p&gt;0.05 not significant (ns), p&lt;0.05 (*), p&lt;0.01 (**), p&lt;0.001 (***).</p></caption><graphic xlink:href="EMS202049-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>SPI-2 effectors SopD2 and GtgE contribute to SPI-2 T3SS-dependent inflammation</title><p><bold>A-B)</bold> Bacterial loads in the liver (left), spleen (middle), and mesenteric lymph node (right) at day 4 post infection (<italic>n</italic> = 3-6 mice per group). Mice were infected as in <xref ref-type="fig" rid="F3">Fig 3A</xref>. Dotted lines denote limit of detection. Horizontal bars denote median. <bold>C)</bold> Levels of gut inflammation at indicated days post infection determined by ELISA quantification of lipocalin-2 (LCN2). Horizonal dotted line (upper) represents typical threshold of moderately inflamed gut, while dotted line (lower) represents limit of detection. Horizontal bars denote median. <bold>D)</bold> Intracellular populations of bacteria recovered from cecal tissue by gentamicin protection assay. Dotted lines denote limit of detection. Horizontal bars denote median. <bold>E-F)</bold> Caecal histology at day 4 post infection. <bold>E)</bold> combined pathology score based on scoring criteria quantifying submucosal edema, epithelial barrier integrity, goblet cell number, and infiltration of polymorphonuclear granulocytes. <bold>F)</bold> representative micrographs of cecum samples stained with hematoxylin and eosin. Lu. lumen, S.E. submucosal edema. <bold>A-C, E)</bold> Statistical differences between WT and indicated groups determined by two-tailed Mann Whitney-U test, (p&gt;0.05 not significant (ns), p&lt;0.05 (*), p&lt;0.01 (**), p&lt;0.001 (***).</p></caption><graphic xlink:href="EMS202049-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Graphical summary effector cohort contributions to inflammation and systemic colonisation.</title><p><bold>A)</bold> Genotypes of six SPI-2 T3SS effector multimutants generated by successive rounds of P22 transduction. Collectively, these strains cover all described SPI-2 effectors in the SL1344 background. <bold>B)</bold> Summary of phenotypic data described in <xref ref-type="fig" rid="F2">Fig 2</xref>-<xref ref-type="fig" rid="F5">5</xref>. S.Tm WT causes high levels of gut inflammation and migrates from the gut to colonise systemic tissue, in a manner dependent on the SPI-2 T3SS. Several multimutants show similar levels of virulence to WT. S.Tm Alpha, Delta, and Zeta showed reduced colonisation of systemic niches, while SPI-2 T3SS-dependent inflammation was impaired during infection with S.Tm Alpha and Delta. <bold>C)</bold> S.Tm WT relies on intracellular niches to induce inflammation and achieve colonisation of systemic tissue. A mutant deficient for SopD2 and GtgE fails to maintain the intracellular niche, leading to reduced levels of gut inflammation and impaired colonisation of systemic sites.</p></caption><graphic xlink:href="EMS202049-f006"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Strains used in this study</title></caption><table frame="below" rules="rows"><thead><tr><th align="left" valign="top">Strain name</th><th align="left" valign="top">Strain number</th><th align="left" valign="top">Relevant genotype</th><th align="left" valign="top">Resistance*</th><th align="left" valign="top">Reference</th></tr></thead><tbody><tr><td align="left" valign="top"><italic>S</italic>.Tm SL1344</td><td align="left" valign="top">SB300</td><td align="left" valign="top">Wild-type</td><td align="left" valign="top">Sm</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R56">56</xref>)</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Δ<italic>invG</italic></td><td align="left" valign="top">SB161</td><td align="left" valign="top">Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R28">28</xref>)</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Δ<italic>ssaV</italic></td><td align="left" valign="top">M2730</td><td align="left" valign="top">Δ<italic>ssaV</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R60">60</xref>)</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Δ<italic>invG</italic>Δ<italic>ssaV</italic></td><td align="left" valign="top">M2702</td><td align="left" valign="top">Δ<italic>invG</italic> Δ<italic>ssaV</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R60">60</xref>)</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Efl</td><td align="left" valign="top">NA170</td><td align="left" valign="top">Δ<italic>spvR</italic> Δ<italic>pipAB</italic> Δ<italic>pipB2</italic><break/>Δ<italic>gtgA</italic> Δ<italic>sifB</italic> Δ<italic>gtgEssel</italic><break/>Δ<italic>steBsseJ</italic> Δ<italic>pipD</italic> Δ<italic>sseL</italic><break/>Δ<italic>gogBsteE</italic> Δ<italic>sopD2</italic> Δ<italic>slrp</italic><break/>Δ<italic>steA</italic> Δ<italic>steDsseK2</italic> Δ<italic>sspH2</italic><break/>Δ<italic>sseK3</italic> Δ<italic>steC</italic> Δ<italic>cigR</italic><break/>Δ<italic>sseK1</italic> Δ<italic>srfJ</italic> Δ<italic>sseFG</italic> Δ<italic>sifA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R15">15</xref>)</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Alpha clone 1</td><td align="left" valign="top">T2978</td><td align="left" valign="top">Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>sseFG</italic> Δ<italic>pipB2</italic> Δ<italic>steA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Alpha clone 2</td><td align="left" valign="top">T2979</td><td align="left" valign="top">Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>sseFG</italic> Δ<italic>pipB2</italic> Δ<italic>steA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta clone 1</td><td align="left" valign="top">T2918</td><td align="left" valign="top">Δ<italic>sseK1</italic> Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>gtgA</italic> Δ<italic>gogA</italic> Δ<italic>pipA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta clone 2</td><td align="left" valign="top">T2919</td><td align="left" valign="top">Δ<italic>sseK1</italic> Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>gtgA</italic> Δ<italic>gogA</italic> Δ<italic>pipA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma clone 1</td><td align="left" valign="top">T2974</td><td align="left" valign="top">Δ<italic>steD</italic> Δ<italic>srgE</italic> Δ<italic>sseI</italic> Δ<italic>srfJ</italic> Δ<italic>steE</italic> Δ<italic>g ogB</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma clone 2</td><td align="left" valign="top">T2988</td><td align="left" valign="top">Δ<italic>steD</italic> Δ<italic>srgE</italic> Δ<italic>sseI</italic> Δ<italic>srfJ</italic> Δ<italic>steE</italic> Δ<italic>g ogB</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta clone 1</td><td align="left" valign="top">T2982</td><td align="left" valign="top">Δ<italic>sopD2</italic> Δ<italic>gtgE</italic> Δ<italic>steC</italic> Δ<italic>sseL</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta clone 2</td><td align="left" valign="top">T2984</td><td align="left" valign="top">Δ<italic>sopD2</italic> Δ<italic>gtgE</italic> Δ<italic>steC</italic> Δ<italic>sseL</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon clone 1</td><td align="left" valign="top">T2968</td><td align="left" valign="top">Δ<italic>steB</italic> Δ<italic>cigR</italic> Δ<italic>sspH2</italic> Δ<italic>pipB</italic> Δ<italic>sifB</italic> Δ<italic>slrP</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon clone 2</td><td align="left" valign="top">T2966</td><td align="left" valign="top">Δ<italic>steB</italic> Δ<italic>cigR</italic> Δ<italic>sspH2</italic> Δ<italic>pipB</italic> Δ<italic>sifB</italic> Δ<italic>slrP</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Zeta clone 1</td><td align="left" valign="top">T2860</td><td align="left" valign="top">Δ<italic>spvR</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Zeta clone 2</td><td align="left" valign="top">T2861</td><td align="left" valign="top">Δ<italic>spvR</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm WT Tag 1</td><td align="left" valign="top">T3415</td><td align="left" valign="top">WISH 2</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R61">61</xref>)</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Δ<italic>ssaV</italic> Tag 2</td><td align="left" valign="top">T2949</td><td align="left" valign="top">Δ<italic>ssaV</italic> WISH 7</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm <italic>Efl</italic> Tag 3</td><td align="left" valign="top">Z8294</td><td align="left" valign="top">Δ<italic>spvR</italic> Δ<italic>pipAB</italic> Δ<italic>pipB2</italic><break/>Δ<italic>gtgA</italic> Δ<italic>sifB</italic> Δ<italic>gtgEsseI</italic><break/>Δ<italic>steBsseJ</italic> Δ<italic>pipD</italic> Δ<italic>sseL</italic><break/>Δ<italic>gogBsteE</italic> Δ<italic>sopD2</italic> Δ<italic>slrp</italic><break/>Δ<italic>steA</italic> Δ<italic>steDsseK2</italic> Δ<italic>sspH2</italic><break/>Δ<italic>sseK3</italic> Δ<italic>steC</italic> Δ<italic>cigR</italic><break/>Δ<italic>sseK1</italic> Δ<italic>srfJ</italic> Δ<italic>sseFG</italic> Δ<italic>sifA</italic><break/>WISH 3</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Alpha Tag 4</td><td align="left" valign="top">T7400</td><td align="left" valign="top">Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>sseFG</italic> Δ<italic>pipB2</italic> Δ<italic>steA</italic> WISH 5</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta Tag 5</td><td align="left" valign="top">T2964</td><td align="left" valign="top">Δ<italic>sseK1</italic> Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>gtgA</italic> Δ<italic>gogA</italic> Δ<italic>pipA</italic> WISH 49</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma Tag 6</td><td align="left" valign="top">T7403</td><td align="left" valign="top">Δ<italic>steD</italic> Δ<italic>srgE</italic> Δ<italic>sseI</italic> Δ<italic>srfJ</italic> Δ<italic>steE</italic> Δ<italic>g ogB</italic> WISH 19</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta Tag 7</td><td align="left" valign="top">T7401</td><td align="left" valign="top">Δ<italic>sopD2</italic> Δ<italic>gtgE</italic> Δ<italic>steC</italic> Δ<italic>sseL</italic> WISH 10</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon Tag 8</td><td align="left" valign="top">T7402</td><td align="left" valign="top">Δ<italic>steB</italic> Δ<italic>cigR</italic> Δ<italic>sspH2</italic> Δ<italic>pipB</italic> Δ<italic>sifB</italic> Δ<italic>slrP</italic> WISH 15</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Zeta Tag 9</td><td align="left" valign="top">T2950</td><td align="left" valign="top">Δ<italic>spvR</italic> WISH 16</td><td align="left" valign="top">Sm, Amp</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Alpha Δ<italic>invG</italic></td><td align="left" valign="top">T2990</td><td align="left" valign="top">Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>sseFG</italic> Δ<italic>pipB2</italic> Δ<italic>steA</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta Δ<italic>invG</italic></td><td align="left" valign="top">T2954</td><td align="left" valign="top">Δ<italic>sseK1</italic> Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>gtgA</italic> Δ<italic>gogA</italic> Δ<italic>pipA</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma Δ<italic>invG</italic></td><td align="left" valign="top">T2992</td><td align="left" valign="top">Δ<italic>steD</italic> Δ<italic>srgE</italic> Δ<italic>sseI</italic> Δ<italic>srfJ</italic> Δ<italic>steE</italic> Δ<italic>gogB</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta Δ<italic>invG</italic></td><td align="left" valign="top">T2994</td><td align="left" valign="top">Δ<italic>sopD2</italic> Δ<italic>gtgE</italic> Δ<italic>steC</italic> Δ<italic>sseL</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Delta Δ<italic>invG</italic></td><td align="left" valign="top">T2994</td><td align="left" valign="top">Δ<italic>sopD2</italic> Δ<italic>gtgE</italic> Δ<italic>steC</italic> Δ<italic>sseL</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Epsilon Δ<italic>invG</italic></td><td align="left" valign="top">T2996</td><td align="left" valign="top">Δ<italic>steB</italic> Δ<italic>cigR</italic> Δ<italic>sspH2</italic> Δ<italic>pipB</italic> Δ<italic>sifB</italic> Δ<italic>slrP</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Zeta Δ<italic>invG</italic></td><td align="left" valign="top">T2998</td><td align="left" valign="top">Δ<italic>spvR</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Δ<italic>steC</italic> Δ<italic>sseL</italic></td><td align="left" valign="top">Z8278</td><td align="left" valign="top">Δ<italic>steC</italic> Δ<italic>sseL</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Δ<italic>sopD2</italic> Δ<italic>gtgE</italic></td><td align="left" valign="top">T2816</td><td align="left" valign="top">Δ<italic>sopD2::aphT</italic> Δ<italic>gtgE::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Δ<italic>sopD2::sopD2</italic> Δ<italic>gtgE::gtgE</italic></td><td align="left" valign="top">T2856</td><td align="left" valign="top">Δ<italic>sopD2::sopD2</italic> Δ<italic>gtgE::gtgE</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Δ<italic>sopD2</italic> Δ<italic>gtgE</italic> Δ<italic>invG</italic></td><td align="left" valign="top">T2824</td><td align="left" valign="top">Δ<italic>sopD2::aphT</italic> Δ<italic>gtgE::cat</italic> Δ<italic>invG</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 1 clone 1</td><td align="left" valign="top">Z6643</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic>::<italic>aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 1 clone 2</td><td align="left" valign="top">Z6644</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic>::<italic>aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 2 clone 1</td><td align="left" valign="top">Z6655</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic>::<italic>aphT</italic> Δ<italic>sifA</italic>::<italic>cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 2 clone 2</td><td align="left" valign="top">Z6656</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic>::<italic>aphT</italic> Δ<italic>sifA</italic>::<italic>cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 3 clone 1</td><td align="left" valign="top">Z6681</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 3 clone 2</td><td align="left" valign="top">Z6682</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 4 clone 1</td><td align="left" valign="top">Z6693</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ</italic>::<italic>aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 4 clone 2</td><td align="left" valign="top">Z6694</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ</italic>::<italic>aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 5 clone 1</td><td align="left" valign="top">Z8161</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ::aphT</italic> Δ<italic>pipB2::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 5 clone 2</td><td align="left" valign="top">Z8162</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ::aphT</italic> Δ<italic>pipB2::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 6 clone 1</td><td align="left" valign="top">Z8199</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>pipB2</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 6 clone 2</td><td align="left" valign="top">Z8200</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>pipB2</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 7 clone 1</td><td align="left" valign="top">T2976</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>pipB2 steA::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Alpha parent 7 clone 2</td><td align="left" valign="top">T2977</td><td align="left" valign="top">Δ<italic>sseF</italic>Δ<italic>sseG</italic> Δ<italic>sifA</italic> Δ<italic>sseJ</italic> Δ<italic>pipB2 steA::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 1 clone 1</td><td align="left" valign="top">Z5608</td><td align="left" valign="top">Δ<italic>sseK2::cat</italic></td><td align="left" valign="top">Sm, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 1 clone 2</td><td align="left" valign="top">Z5600</td><td align="left" valign="top">Δ<italic>sseKl::cat</italic></td><td align="left" valign="top">Sm, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 2 clone 1</td><td align="left" valign="top">Z5628</td><td align="left" valign="top">Δ<italic>sseK2::cat</italic> Δ<italic>sseK3::aphT</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 2 clone 2</td><td align="left" valign="top">Z5624</td><td align="left" valign="top">Δ<italic>sseKl::cat</italic> Δ<italic>sseK2::aphT</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 3 clone 1</td><td align="left" valign="top">Z5640</td><td align="left" valign="top">Δ<italic>sseK2</italic> Δ<italic>sseK3</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 3 clone 2</td><td align="left" valign="top">Z5636</td><td align="left" valign="top">Δ<italic>sseKl</italic> Δ<italic>sseK2</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 4 clone 1</td><td align="left" valign="top">Z5648</td><td align="left" valign="top">Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>sseKl::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 4 clone 2</td><td align="left" valign="top">Z5650</td><td align="left" valign="top">Δ<italic>sseKl</italic> Δ<italic>sseK2</italic> Δ<italic>sseK3::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 5 clone 1</td><td align="left" valign="top">Z5654</td><td align="left" valign="top">Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>sseKl</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 5 clone 2</td><td align="left" valign="top">Z5656</td><td align="left" valign="top">Δ<italic>sseKl</italic> Δ<italic>sseK2</italic> Δ<italic>sseK3</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 6 clone 1</td><td align="left" valign="top">T2900</td><td align="left" valign="top">Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>sseKl gtgA::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 6 clone 2</td><td align="left" valign="top">T2901</td><td align="left" valign="top">Δ<italic>sseKl</italic> Δ<italic>sseK2</italic> Δ<italic>sseK3 gtgA::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>. Tm Beta parent 7 clone 1</td><td align="left" valign="top">T2904</td><td align="left" valign="top">Δ<italic>sseK2</italic> Δ<italic>sseK3</italic> Δ<italic>sseKl gtgA::aphT gogA::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon Δ<italic>invG</italic></td><td align="left" valign="top">T2905</td><td align="left" valign="top"><italic>ΔsseK1 ΔsseK2 ΔsseK3 gtgA::aphT gogA::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta parent 8 clone 1</td><td align="left" valign="top">T2914</td><td align="left" valign="top"><italic>ΔsseK2 ΔsseK3 ΔsseK1 ΔgtgA ΔgogA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta parent 8 clone 2</td><td align="left" valign="top">T2915</td><td align="left" valign="top"><italic>ΔsseK1 ΔsseK2 ΔsseK3 ΔgtgA ΔgogA</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta parent 9 clone 1</td><td align="left" valign="top">T2916</td><td align="left" valign="top"><italic>ΔsseK2 ΔsseK3 ΔsseK1 ΔgtgA ΔgogA pipA::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Beta parent 9 clone 2</td><td align="left" valign="top">T2917</td><td align="left" valign="top"><italic>ΔsseK1 ΔsseK2 ΔsseK3 ΔgtgA ΔgogA pipA::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 1 clone 1</td><td align="left" valign="top">Z6539</td><td align="left" valign="top"><italic>ΔsteD::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 1 clone 2</td><td align="left" valign="top">Z6540</td><td align="left" valign="top"><italic>ΔsteD::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 2 clone 1</td><td align="left" valign="top">Z8117</td><td align="left" valign="top"><italic>ΔsteD::aphT ΔsrgE::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 2 clone 2</td><td align="left" valign="top">Z8118</td><td align="left" valign="top"><italic>ΔsteD::aphT ΔsrgE::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 3 clone 1</td><td align="left" valign="top">Z8193</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 3 clone 2</td><td align="left" valign="top">Z8194</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 4 clone 1</td><td align="left" valign="top">Z8211</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 4 clone 2</td><td align="left" valign="top">Z8212</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 5 clone 1</td><td align="left" valign="top">Z8215</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel::aphT ΔsrfJ::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 5 clone 2</td><td align="left" valign="top">Z8216</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel::aphT ΔsrfJ::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 6 clone 1</td><td align="left" valign="top">Z8221</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 6 clone 2</td><td align="left" valign="top">Z8222</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 7 clone 1</td><td align="left" valign="top">Z8227</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ ΔsteE::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 7 clone 2</td><td align="left" valign="top">Z8228</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ ΔsteE::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 8 clone 1</td><td align="left" valign="top">T2902</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ ΔsteE</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 8 clone 2</td><td align="left" valign="top">T2903</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ ΔsteE</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 9 clone 1</td><td align="left" valign="top">T2972</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ ΔsteE gogB::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Gamma parent 9 clone 2</td><td align="left" valign="top">T2986</td><td align="left" valign="top"><italic>ΔsteD ΔsrgE Δssel ΔsrfJ ΔsteE gogB::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 1 clone 1</td><td align="left" valign="top">Z6535</td><td align="left" valign="top"><italic>ΔsteC::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 1 clone 2</td><td align="left" valign="top">Z6536</td><td align="left" valign="top"><italic>ΔsteC::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 2 clone 1</td><td align="left" valign="top">Z8270</td><td align="left" valign="top"><italic>ΔsteC::aphT ΔsseL::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 2 clone 2</td><td align="left" valign="top">Z8271</td><td align="left" valign="top"><italic>ΔsteC::aphT ΔsseL::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 3 clone 1</td><td align="left" valign="top">Z8278</td><td align="left" valign="top"><italic>ΔsteC ΔsseL</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 3 clone 2</td><td align="left" valign="top">Z8279</td><td align="left" valign="top"><italic>ΔsteC ΔsseL</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 4 clone 1</td><td align="left" valign="top">Z8286</td><td align="left" valign="top"><italic>ΔsteC</italic>Δ<italic>sseL sopD2::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 4 clone 2</td><td align="left" valign="top">Z8289</td><td align="left" valign="top"><italic>ΔsteC</italic>Δ<italic>sseL sopD2::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 5 clone 1</td><td align="left" valign="top">T2804</td><td align="left" valign="top"><italic>ΔsteC</italic>Δ<italic>sseL sopD2::aphT gtgE::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Delta parent 5 clone 2</td><td align="left" valign="top">T2805</td><td align="left" valign="top"><italic>ΔsteC</italic>Δ<italic>sseL sopD2::aphT gtgE::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 1 clone 1</td><td align="left" valign="top">Z6525</td><td align="left" valign="top"><italic>ΔsteB::cat</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 1 clone 2</td><td align="left" valign="top">Z6526</td><td align="left" valign="top"><italic>ΔsteB::cat</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 2 clone 1</td><td align="left" valign="top">Z8115</td><td align="left" valign="top"><italic>ΔsteB::cat ΔcigR::aphT</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 2 clone 2</td><td align="left" valign="top">Z8116</td><td align="left" valign="top"><italic>ΔsteB::cat ΔcigR::aphT</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 3 clone 1</td><td align="left" valign="top">Z8191</td><td align="left" valign="top"><italic>ΔsteB ΔcigR</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 3 clone 2</td><td align="left" valign="top">Z8192</td><td align="left" valign="top"><italic>ΔsteB ΔcigR</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 4 clone 1</td><td align="left" valign="top">Z8209</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 4 clone 2</td><td align="left" valign="top">Z8210</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 5 clone 1</td><td align="left" valign="top">Z8219</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2::aphT pipB::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 5 clone 2</td><td align="left" valign="top">Z8220</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2::aphT pipB::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 6 clone 1</td><td align="left" valign="top">Z8223</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2 ΔpipB</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 6 clone 2</td><td align="left" valign="top">Z8224</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2 ΔpipB</italic></td><td align="left" valign="top">Sm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 7 clone 1</td><td align="left" valign="top">T2924</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2 ΔpipB slrP::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 7 clone 2</td><td align="left" valign="top">T2925</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2 ΔpipB slrP::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 8 clone 1</td><td align="left" valign="top">T2935</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2 ΔpipB slrP::aphT sifB::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Epsilon parent 8 clone 2</td><td align="left" valign="top">T2936</td><td align="left" valign="top"><italic>ΔsteB ΔcigR ΔsspH2 ΔpipB slrP::aphT sifB::cat</italic></td><td align="left" valign="top">Sm, Kan, Cm</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Zeta parent 1 clone 1</td><td align="left" valign="top">Z8264</td><td align="left" valign="top"><italic>ΔspvR::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr><tr><td align="left" valign="top"><italic>S</italic>.Tm Zeta parent 1 clone 2</td><td align="left" valign="top">Z8265</td><td align="left" valign="top"><italic>ΔspvR::aphT</italic></td><td align="left" valign="top">Sm, Kan</td><td align="left" valign="top">This study</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p><bold>Resistances:</bold> Sm = 50 μg/ml streptomycin, Amp = 50 μg/ml ampicillin, Cm = 15 μg/ml chloramphenicol, Kan = 50 μg/ml kanamycin.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Primers used in this study</title></caption><table frame="below" rules="rows"><thead><tr><th align="left" valign="top">Primer name</th><th align="left" valign="top">Sequence</th><th align="left" valign="top">Source</th><th align="left" valign="top">Purpose</th></tr></thead><tbody><tr><td align="left" valign="top">slrP_FW</td><td align="left" valign="top">GACGACTGTGACCTCTTATTTAAA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of slrP deletion</td></tr><tr><td align="left" valign="top">slrP_RV</td><td align="left" valign="top">AAAAAGCGCTACAGGCGTTGG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of slrP deletion</td></tr><tr><td align="left" valign="top">sopD2_FW</td><td align="left" valign="top">TTTCTAAACCCAGGCTGATTCAA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sopD2 deletion</td></tr><tr><td align="left" valign="top">sopD2_RV</td><td align="left" valign="top">CCATGTAATGGGTTTGACTGAAA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sopD2 deletion</td></tr><tr><td align="left" valign="top">gtgA_FW</td><td align="left" valign="top">TAGGCAATGAGTCCGGCCA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gtgA deletion</td></tr><tr><td align="left" valign="top">gtgA_RV</td><td align="left" valign="top">CCTTGGCAGGGCTCGCT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gtgA deletion</td></tr><tr><td align="left" valign="top">ssel_FW</td><td align="left" valign="top">TATTGTGAAATTAAGACCAGGAAGA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseI deletion</td></tr><tr><td align="left" valign="top">ssel_RV</td><td align="left" valign="top">GATGTTGTTGTCGATCTCCAC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseI deletion</td></tr><tr><td align="left" valign="top">gtgE_FW</td><td align="left" valign="top">ATGCGACAATACAATAAAAACATATCA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gtgE deletion</td></tr><tr><td align="left" valign="top">gtgE_RV</td><td align="left" valign="top">AGCTTCCCCGTAGGAAATTGA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gtgE deletion</td></tr><tr><td align="left" valign="top">pipA_FW</td><td align="left" valign="top">GTTGGCTTTGTCTGAATCATAGC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of pipA deletion</td></tr><tr><td align="left" valign="top">pipA_RV</td><td align="left" valign="top">GCCCCTTTGTTTTTTTAGGCG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of pipA deletion</td></tr><tr><td align="left" valign="top">pipB_FW</td><td align="left" valign="top">CAAAGCTCTAAATACAAAAATCACC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of pipB deletion</td></tr><tr><td align="left" valign="top">pipB_RV</td><td align="left" valign="top">TGAAACTTAGGGGCGGGGTT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of pipB deletion</td></tr><tr><td align="left" valign="top">sifA FW</td><td align="left" valign="top">GCGCCCGCAGTTGAGATAAA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sifA deletion</td></tr><tr><td align="left" valign="top">sifA_RV</td><td align="left" valign="top">GCCTGGCAAGAGGTTACTCA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sifA deletion</td></tr><tr><td align="left" valign="top">sseF_FW</td><td align="left" valign="top">CGGATGCCTCATGGAGTGA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseF deletion</td></tr><tr><td align="left" valign="top">sseG_RV</td><td align="left" valign="top">CATCGTAAGGATACTGGCAACA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseG deletion</td></tr><tr><td align="left" valign="top">srgE_FW</td><td align="left" valign="top">ATGAGTTATTGACCACTGAATTTTCT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of srgE deletion</td></tr><tr><td align="left" valign="top">srgE_RV</td><td align="left" valign="top">GAGTAACTTTACGACAATTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of srgE deletion</td></tr><tr><td align="left" valign="top">steA_FW</td><td align="left" valign="top">CTGAAAATGTATGCCTTTGAGCAA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steA deletion</td></tr><tr><td align="left" valign="top">steA_RV</td><td align="left" valign="top">TTCTGAGAATCTCTTTGCGACAC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steA deletion</td></tr><tr><td align="left" valign="top">sifB_FW</td><td align="left" valign="top">AAAGCAAAAATCAGGTGTTTCACC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sifB deletion</td></tr><tr><td align="left" valign="top">sifB_RV</td><td align="left" valign="top">TTCGTTCCATAGTAAATCCATTATTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sifB deletion</td></tr><tr><td align="left" valign="top">steB FW</td><td align="left" valign="top">CTTAGTCAATGTGGACAAAAAATCAAA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steB deletion</td></tr><tr><td align="left" valign="top">steB_RV</td><td align="left" valign="top">ACGGCAGAACTTCCCATAGC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steB deletion</td></tr><tr><td align="left" valign="top">sseJ FW</td><td align="left" valign="top">AAGAAGCGTAATTCCATATACACC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseJ deletion</td></tr><tr><td align="left" valign="top">sseJ_RV</td><td align="left" valign="top">CAATCGGCAGCAAAGATAGCAT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseJ deletion</td></tr><tr><td align="left" valign="top">steC_FW</td><td align="left" valign="top">CAAACTGGCAAATCAAAGAGTCT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steC deletion</td></tr><tr><td align="left" valign="top">steC_RV</td><td align="left" valign="top">TTGCATCTCCGCTACAGGCT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steC deletion</td></tr><tr><td align="left" valign="top">sseK3_FW</td><td align="left" valign="top">TTAAGCCCCCCCTAACCAAGTAAAAACTATCGTTTCAG AT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseK3 deletion</td></tr><tr><td align="left" valign="top">sseK3_RV</td><td align="left" valign="top">TTCACCACGGCACGCAGGTCATCCAATTTAATGGAGGT AC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseK3 deletion</td></tr><tr><td align="left" valign="top">sseK2_FW</td><td align="left" valign="top">GTCGGACTCAGGACTTAGCATTGTGACGTTAACGTTTA AA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseK2 deletion</td></tr><tr><td align="left" valign="top">sseK2_RV</td><td align="left" valign="top">TGAAAGTTCTGTAGAGAAACTTGAATGTGAAATTGAGG TA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseK2 deletion</td></tr><tr><td align="left" valign="top">steD_FW</td><td align="left" valign="top">CCTATTTAGATGATGGCTTAGCG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steD deletion</td></tr><tr><td align="left" valign="top">steD_RV</td><td align="left" valign="top">CTATATAAGTCATAAGCCTCTGGT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steD deletion</td></tr><tr><td align="left" valign="top">sspH2_FW</td><td align="left" valign="top">TCTGCACCTTCTGAAGCCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sspH2 deletion</td></tr><tr><td align="left" valign="top">sspH2_RV</td><td align="left" valign="top">GTCATCCGGATATTTCACCTGT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sspH2 deletion</td></tr><tr><td align="left" valign="top">sseL_FW</td><td align="left" valign="top">GCAATATCTCTTGTATCGACGC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseL deletion</td></tr><tr><td align="left" valign="top">sseL_RV</td><td align="left" valign="top">GACAGCAGGTTGGCGATGT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseL deletion</td></tr><tr><td align="left" valign="top">gogB_FW</td><td align="left" valign="top">TAGGTTCTAAATCTTGCCTGAATG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gogB deletion</td></tr><tr><td align="left" valign="top">gogB_RV</td><td align="left" valign="top">AAGTTGGCATGTAGTCTAGAGTTA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gogB deletion</td></tr><tr><td align="left" valign="top">steE_FW</td><td align="left" valign="top">TCTTGTTGTGATGAGATTCGTATATA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steE deletion</td></tr><tr><td align="left" valign="top">steE_RV</td><td align="left" valign="top">AAATCACACAATCCGGACTGAG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of steE deletion</td></tr><tr><td align="left" valign="top">gogA_FW</td><td align="left" valign="top">GCTTTTAGCTTAATTGATTGCGTG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gogA deletion</td></tr><tr><td align="left" valign="top">gogA_RV</td><td align="left" valign="top">ATTCCATTTGAGGCTGCCATTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of gogA deletion</td></tr><tr><td align="left" valign="top">pipB2_FW</td><td align="left" valign="top">TTATTATGTAACCAGACGTAAAGGG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of pipB2 deletion</td></tr><tr><td align="left" valign="top">pipB2_RV</td><td align="left" valign="top">TTTTACCGTCGCATACTCCTGT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of pipB2 deletion</td></tr><tr><td align="left" valign="top">cigR_FW</td><td align="left" valign="top">ATAAGCTGCTGTTGGCGAGC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of cigR deletion</td></tr><tr><td align="left" valign="top">cigR_RV</td><td align="left" valign="top">CGTAGCGAGTCAAACCTCAC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of cigR deletion</td></tr><tr><td align="left" valign="top">sseK1_FW</td><td align="left" valign="top">CTGGCAGGGTATTTATGTATCCTCCGGTTAATGCTTAG TT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseK1 deletion</td></tr><tr><td align="left" valign="top">sseK1_RV</td><td align="left" valign="top">AATGCCGTATATCTCCGTTCTGAACAGCACTGCGATTT TA</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of sseK1 deletion</td></tr><tr><td align="left" valign="top">srfJ_FW</td><td align="left" valign="top">GACTGGAAACAGCGCTTTATTGATGCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of srfJ deletion</td></tr><tr><td align="left" valign="top">srfJ_RV</td><td align="left" valign="top">GTCGCTTCATTAAATCCCAGCT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of srfJ deletion</td></tr><tr><td align="left" valign="top">spvR_FW</td><td align="left" valign="top">CATAATCCTATCCAGTAACCCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of spvB deletion</td></tr><tr><td align="left" valign="top">spvR_RV</td><td align="left" valign="top">GGTGAACTACCGCTATGGAG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Genotyping of spvB deletion</td></tr><tr><td align="left" valign="top">pipB_red_FW</td><td align="left" valign="top">CCTATAAGGAGTCGGCTCACTTCCATAAGAAGGAATCA AAATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of pipB</td></tr><tr><td align="left" valign="top">pipB_red_RV</td><td align="left" valign="top">TGTTTGAATACTTCTTGTTTATAAAATCCCTTTATCTC GATGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of pipB</td></tr><tr><td align="left" valign="top">srgE_red_F W</td><td align="left" valign="top">ACTACACTGGGAAATCGTTGCGTGGTGGTTCCGGAGAT AGATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of srgE</td></tr><tr><td align="left" valign="top">srgE_red_RV</td><td align="left" valign="top">AATGCCAGACTTCCGCTACCAGACGGTATACACAGTAT TATGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of srgE</td></tr><tr><td align="left" valign="top">sseJ_red_F W</td><td align="left" valign="top">TTATTTGCTAAAGCGTGTTTAATAAAGTAAGGAGGACA CTATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sseJ</td></tr><tr><td align="left" valign="top">sseJ_red_RV</td><td align="left" valign="top">AGCTGTGTTTTGCTCAAGGCGTACCGCAGCCGATGGAA CTTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sseJ</td></tr><tr><td align="left" valign="top">gtgA_red_F W</td><td align="left" valign="top">AATGTTAATTCCATGTAATAAAAAGGATGTGTAACTCA TCATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gtgA</td></tr><tr><td align="left" valign="top">gtgA_red_RV</td><td align="left" valign="top">GTGTTGTAGCATCGTGGGATTTTGCATTTTTTGATGAG TGTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gtgA</td></tr><tr><td align="left" valign="top">gtgE_red_F W</td><td align="left" valign="top">TATAATTACATTAACAAAATTACTATTCGGCGAGTATA TTATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gtgE</td></tr><tr><td align="left" valign="top">gtgE_red_RV</td><td align="left" valign="top">AATTATCTTGGTAAAGGTTAACTATCATAAAATGGTAC ACTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gtgE</td></tr><tr><td align="left" valign="top">sseL_red_F W</td><td align="left" valign="top">ATTGAGCATACCGCAATTTCACAGCTTATATACAGAAG AGATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sseL</td></tr><tr><td align="left" valign="top">sseL_red_RV</td><td align="left" valign="top">AGGATAAGAGCCTAATGGGATAGGCTCTAAGTACTCAC CATGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sseL</td></tr><tr><td align="left" valign="top">gogB_red_F W</td><td align="left" valign="top">ATTGAAAAAGCGCATGAAAATAGGATTCCAACCAGCCA TAATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gogB</td></tr><tr><td align="left" valign="top">gogB_red_R V</td><td align="left" valign="top">GCTCTATATATAAATATATTAATTGCATATTTTTTTAA AGTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gogB</td></tr><tr><td align="left" valign="top">gogA_red_F W</td><td align="left" valign="top">AATGTTAATTCCATGTAATAAAAAGGATGTGTAACTCA TCATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gogA</td></tr><tr><td align="left" valign="top">gogA_red_R V</td><td align="left" valign="top">GTGTTGTAGCATCGTGGGATTTTGCATTTTTTGATGAG TGTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of gogA</td></tr><tr><td align="left" valign="top">sseFsseG_re d_FW</td><td align="left" valign="top">AATGGTTGATACTCTTATTGCTTAAATAACAGAACGAA ATATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sseFsseG</td></tr><tr><td align="left" valign="top">sseFsseG_re d_RV</td><td align="left" valign="top">TTTAGAAAGCAATGAACATCCGGTATATACCTGAAAAC GATGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sseFsseG</td></tr><tr><td align="left" valign="top">sspH2_red_F W</td><td align="left" valign="top">CGGACAGATACTATATGTAAATTTATAAAGGTTTTTTG TTATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sspH2</td></tr><tr><td align="left" valign="top">sspH2_red_R V</td><td align="left" valign="top">GGAATATCTTTGTCGCACCGCACCTCATTCACCTGGTG CATGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sspH2</td></tr><tr><td align="left" valign="top">sopD2_red_F W</td><td align="left" valign="top">TTGGATCTTGCTTTCGCGGTAAATAATCAAGGGAGTTA TTATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sopD2</td></tr><tr><td align="left" valign="top">sopD2_red_ RV</td><td align="left" valign="top">AAAAAAGGCTCCATATCAGTGGGGCCTTTTTAATGACT TTTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sopD2</td></tr><tr><td align="left" valign="top">steA_red_FW</td><td align="left" valign="top">GACATATAAAGCTATTGAGCAAAATTTGAAGGAGTAGG ATATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of steA</td></tr><tr><td align="left" valign="top">steA_red_RV</td><td align="left" valign="top">AGTCTGATTTCTAACAAAACTGGCTAAACATAAACGCT TTTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of steA</td></tr><tr><td align="left" valign="top">steB_red_FW</td><td align="left" valign="top">TCATTATTGTTAGTTTGAAATCAATCTCAGGTAATAAT CCATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of steB</td></tr><tr><td align="left" valign="top">steB_red_RV</td><td align="left" valign="top">CTGTGGAATAGCAATGCCGGGAAGGACATGGCATGACA CTTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of steB</td></tr><tr><td align="left" valign="top">steC_red_F W</td><td align="left" valign="top">TTGCATGTGTATTATAATAAATTTTCAGAGGATGAGAC ATATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of steC</td></tr><tr><td align="left" valign="top">steC_red_RV</td><td align="left" valign="top">TGTGCCCCCGGCGATTCGCAGAAAAGAACGGAACTAAA TGTGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of steC</td></tr><tr><td align="left" valign="top">sifB_red_FW</td><td align="left" valign="top">CCAGTAATGAAGTATCATATAATCACTTGTGGTCTACA TTATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sifB</td></tr><tr><td align="left" valign="top">sifB_red_RV</td><td align="left" valign="top">ATTGCCAGGGGATTGTAAATCCATACTATTTATGGTGT GATGTGTAGGCTGGAGCTGCTTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of sifB</td></tr><tr><td align="left" valign="top">slrP_red_FW</td><td align="left" valign="top">TCTGTTACTTTAGGTTACGTTCAGATCAGGTAGGGAAA ATATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of slrP</td></tr><tr><td align="left" valign="top">slrP_red_RV</td><td align="left" valign="top">GTAAACAGGCTCTCTCCCTCTTCTGATAAACTGCGTTC AGATATGAATATCCTCCTTAGTTCC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Lambda red replacement of slrP</td></tr><tr><td align="left" valign="top">BamHI_sopD 2_FW</td><td align="left" valign="top">ATTTGGATCCACAGGCGCGAAACCAGTC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Complementat ion insert for sopD2 with restriction sites</td></tr><tr><td align="left" valign="top">Notl_sopD2_ RV</td><td align="left" valign="top">ATTTGCGGCCGCATCAAAGGCGATGTTCTGAACTT</td><td align="left" valign="top">This study</td><td align="left" valign="top">Complementat ion insert for sopD2 with restriction sites</td></tr><tr><td align="left" valign="top">BamHI_gtgE _FW</td><td align="left" valign="top">ATTTGGATCCTTCGGCATCGAGGTCAAAGG</td><td align="left" valign="top">This study</td><td align="left" valign="top">Complementat ion insert for gtgE with restriction sites</td></tr><tr><td align="left" valign="top">NotI_gtgE_R V</td><td align="left" valign="top">ATTTGCGGCCGCGGGACAGTCATCCGTTTTTAAC</td><td align="left" valign="top">This study</td><td align="left" valign="top">Complementat ion insert for gtgE with restriction sites</td></tr></tbody></table></table-wrap></floats-group></article>